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Abstract 
 
  One of the greatest risk factors for contracting cancer is aging. By the year 2030 
the number of new cancer cases will balloon to 2.3 million per year. Malnutrition is a 
common problem identified in cancer patients and is recognized as an important 
component of adverse outcomes, including increased morbidity and mortality and 
decreased quality of life (QOL). Nutritional risk is not consistently assessed in the 
older adult cancer patient population.  
  The purpose of this study was to identify variables related to nutritional risk in the 
cancer patient 65 years and older receiving systemic treatments via Phase I clinical trials. The 
study described the relationship between nutritional risk and the four domains of QOL 
(physical, social, emotional, and functional). This study was guided conceptually by an 
adapted version of the City of Hope QOL model, focusing on the four key domains of QOL. 
The instrument chosen to measure QOL was the FACT-G (Version 4), created by Cella, et al. 
(1993), is a cancer specific version of the FACIT (Functional Assessment of Chronic Illness 
Therapy) Measurement System. It contains a 27-item compilation of general questions 
divided into the four QOL domains.  
A sample of 73 patients, with a mean age of 71, were successfully accrued for this 
study from an NCI RO1 aimed at integrating supportive care for cancer patients on Phase I 
clinical trials using the MNA-SF instrument to assess for nutritional risk. The population was 
predominantly Caucasian and overall well-educated. Most of the patients were Protestant and 
were married or partnered, living with a spouse or child. Most were retired with an annual 
income of $50,000 or greater. The participants were almost equally divided by male and 
female. 
 Study findings revealed that the strongest correlation with nutritional risk was BMI 
status (r = .47, p < .0001). Multiple regression analysis demonstrated that the factors 
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associated with nutritional risk included BMI, previous chemotherapy and physical subscale 
of the FACT-G QOL instrument. Additional descriptive data reinforced the importance of 
nursing assessment and intervention to support nutritional status.  
 Nutrition impacts all dimensions of QOL and will be even more important in an aging 
population. Nursing research can contribute greatly to advancing this area of practice.  
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Chapter 1. Background and Significance 
Introduction 
 The purpose of chapter one is to describe the background and significance of 
nutritional risk assessment for the older cancer patient undergoing systemic treatment via 
Phase I clinical trials. The chapter presents the study problem statement to guide the research.  
An unprecedented shift in demographics is underway in the United States. More 
than 1.6 million people receive a cancer diagnosis annually, and that number is 
climbing sharply (IOM, 2013). One of the greatest risk factors for contracting cancer 
is aging. The mean age at the time of a cancer diagnosis is at age 66, and coincidently 
the first wave of baby boomers is now turning 70. As of 2013, approximately 10, 000 
more individuals turn 70 each day. Additionally, by the year 2030 the number of new 
cancer cases will balloon to 2.3 million per year, a projected increase of 45% (ACS, 
2013; NCI, 2013). Given the increased geriatric population in oncology, the research 
is timely. 
Nutrition plays a major, but not always fully understood, role in many aspects of 
cancer development and treatment. Malnutrition is a common problem identified in cancer 
patients and is recognized as an important component of adverse outcomes, including 
increased morbidity and mortality and decreased QOL. Weight loss associated with 
malnutrition has also been identified as an indicator of poor prognosis in cancer patients 
(McMahon, Decker & Ottery, 2001). 
Study Purpose 
 Taking into account the critical importance of this clinical problem, the purpose of 
this study describes the nutritional risk of cancer patients 65 years and older who are 
receiving systemic treatments via Phase I clinical trials. It describes the relationship between 
nutritional risk and the four domains of QOL (physical, social, emotional, and functional). 
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Background 
 The principles of nutrition care for people diagnosed with cancer were developed in 
1979 and are still very relevant today. Proactive nutritional care can prevent or reduce the 
complications typically associated with the treatment of cancer (NCI, 2016). Many 
nutritional problems stem from local effects of the tumor. Tumors in the gastrointestinal 
tract, for example, can cause obstruction, nausea, vomiting, impaired digestion, and/or 
malabsorption. In addition to the effects of the tumor, marked alterations in normal 
metabolism of carbohydrates, protein, and/or fats can occur (NCI, 2016). 
The nutritional prognostic indicators most recognized as being predictive of poor 
outcome include weight loss, wasting, and malnutrition (Bales, 2001). In addition, 
significant weight loss at the time of diagnosis has been associated with decreased survival 
and reduced response to surgery, radiation therapy, and/or chemotherapy (Bales, 2001). 
Malnutrition and accompanying weight loss can be part of an individual’s 
presentation or can be caused or aggravated by treatments for the disease. Identification of 
nutrition problems and treatment of nutrition-related symptoms have been shown to 
stabilize or reverse weight loss in 50% to 88% of oncology patients (NCI, 2016). Screening 
and nutrition assessment should be interdisciplinary; the healthcare team (e.g., physicians, 
nurses, registered dietitians, social workers, psychologists) should all be involved in 
nutritional management throughout the continuum of cancer care (NCI, 2016). 
The nutritional status of patients diagnosed with cancer entering the treatment 
process varies. Not everyone begins therapy with anorexia, weight loss, and other 
symptoms of nutritional problems. For patients who have such symptoms, however, 
anticancer therapies can complicate the treatment and expected recovery (Bens, 
2015). 
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Many individuals will present with preexisting co-morbid diseases and illnesses 
that further complicate their treatment. Surgery, chemotherapy, and radiation can have a 
direct (or mechanical) and/or an indirect (or metabolic) negative effect on nutritional 
status (Bens 2015). The success of the anticancer therapy will be influenced by a 
patient’s ability to tolerate therapy, which will, in turn, be affected by nutritional status 
preceding treatment. The treating clinician should assess baseline nutritional status and 
be aware of the possible implications of the various therapies. Patients receiving 
aggressive cancer therapies typically need aggressive nutrition management. Bens (2015) 
recommends physicians should have required nutrition education to incorporate dietary 
recommendations into all cancer therapy protocols. 
Nutritional Risk 
What does it mean to be at nutritional risk? Being at nutritional risk does not 
necessarily mean that the older cancer patient undergoing therapy is malnourished, yet 
many professionals use the two terms interchangeably. Even though this is a particularly 
vulnerable group, the assessment of nutritional risk continues to be unmet in many 
treatment protocols. Although many assessment tools exist, they are sparsely and 
inconsistently utilized (Bales, 2001).  
Nutritional risk assessment of the older adult cancer population undergoing therapy is 
a significant, under-recognized issue, and is not well-defined. Additionally, in examining 
the needs of the older person with the added burden of a cancer diagnosis and undergoing 
treatment, the gaps in assessment of the nutritional status and evaluation of dietary 
deficiencies of this group can be readily addressed (Isenring, Banks, Ferguson, & Bauer, 
2012).  
Malnutrition and associated weight loss is a common and persistent problem in older 
patients during and after cancer treatments. Evidence suggests that malnutrition is an 
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important predictor of poor QOL, treatment-related toxicity, increased morbidity, and poor 
prognosis in older cancer patients (McMahon, Decker & Ottery, 1998).  
Despite the current evidence, strategies to assess and identify patients at risk for 
malnutrition are not fully integrated into routine oncology care. Possible causes include the 
following: 1) the definition of nutritional risk is poorly understood (Isenring & Elia, 2015; 
van Bokhorst-van der Schueren, et al., 2014), and 2) there is a deficiency in tools to assess 
nutritional risk that is relevant to older cancer survivors (Isenring & Elia, 2015; van 
Bokhorst-van der Schueren, et al., 2014).  
Problem Statement 
The World Health Organization (WHO) defines nutritional wellness/poor nutrition as, 
“The intake of food, considered in relation to the body’s dietary needs. Good nutrition, an 
adequate, well-balanced diet combined with regular physical activity is a cornerstone of good 
health. Poor nutrition is the absence of a well-balanced diet which can lead to reduced 
immunity, increased susceptibility to disease, impaired physical and mental development, and 
reduced productivity” (WHO, 2014). For cancer patients, nutritional problems stem from a 
number of causes. Tumors in the gastrointestinal tract, for example, can cause obstruction, 
nausea, vomiting, impaired digestion, and/or malabsorption. In addition to the effects of the 
tumor, marked alterations in normal metabolism of carbohydrates, protein, and/or fats can 
occur (NCI, 2016). Malnutrition and accompanying weight loss can be part of an individual’s 
presentation or can be caused or aggravated by treatments for the disease. Anticancer 
therapies can complicate nutritional status (Bens, 2015). In addition, significant weight loss at 
the time of diagnosis has been associated with decreased survival and reduced response to 
surgery, radiation therapy, and/or chemotherapy.  
The nutritional prognostic indicators most recognized as being predictive of poor 
outcome include weight loss, wasting, and malnutrition (Bales, 2001). Nutritional relative risk 
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assessment is an approach to systematically place a specific risk factor in context of other 
contributing risk factors, including health and nutritional factors, to the overall disease 
outcome. The Institute of Medicine (IOM), (now renamed the National Academy of 
Medicine) report of 2013 mandates that a complete and ongoing nutritional status should be 
assessed and documented, according to the patient’s unique vulnerabilities including physical, 
psychological, social, and spiritual needs (Extermann & Hurria, 2009; IOM, 2013). Since the 
1980’s many nutritional assessment tools have been developed; these include the Subjective 
Global Assessment (SGA), the Mini Nutritional Assessment (MNA-SF), the Malnutrition 
Universal Screening Tool (MUST) and Comprehensive Geriatric Assessment (CGA). 
Although many assessment tools exist, they are utilized sparsely and inconsistently (Isenring, 
Banks, Ferguson& Bauer, 2012).  
Nutritional Risk Factors 
The nutritional prognostic indicators most recognized as being predictive of poor 
outcome include weight loss, wasting, and malnutrition (Bales, 2001). Nutritional relative 
risk assessment is an approach to systematically place a specific risk factor in context of other 
contributing risk factors, including health and nutritional factors, to the overall disease 
outcome.  
Effects of Nutritional Risk Assessment 
Consequently, comprehensive nutritional risk assessment in older cancer patients 
remains an issue. Identification of nutritional problems has been shown to stabilize or reverse 
weight loss in 50% to 88% of oncology patients. Early identification and nutritional 
intervention for older cancer patients can decrease hospital admissions, morbidity, mortality, 
healthcare costs, resource utilization, and improve QOL (Isenring, Banks, Ferguson & Bauer, 
2012).   
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Chapter 2. Review of the Literature 
 The purpose of chapter two is to present the literature synthesis that was completed in 
the area of nutritional risk assessment. The chapter presents the literature review 
methodology, findings, and implications for the proposed study.  
This literature review explored and identified gaps in the current research 
related to assessment of nutritional risk in the cancer patient 65 and older undergoing 
systemic treatment via Phase I cancer therapy. The review focused on nutritional risk 
assessment, rather than the broad issue of nutrition. Review of actual instruments to 
assess nutritional risk status provided understanding of the factors influencing 
nutritional risk.  Specifically, the systematized review is directed utilizing the 
Preferred Reporting Items of Systematic Reviews and Meta-analysis (PRISMA) 
statement (Hutton, et al., 2015; Moher, Liberati, & Altman, 2009).  
Nutritional Risk in Older Cancer Patients 
Nutritional risk assessment is an approach to systematically place a specific risk 
factor in context of other contributing risk factors, including health and nutritional factors, 
to the overall disease outcome. The definition of nutritional risk is poorly understood at 
best, and lacks consistency in its meaning (Isenring & Elia, 2015; van Bokhorst-van der 
Schueren, et al., 2014). The World Health Organization (WHO) definition of nutritional 
wellness is “the intake of food, considered in relation to the body’s dietary needs.”  There is 
also a deficiency in the interpretation of the tools utilized in measuring nutritional risk.  
Older cancer patients and their families experience numerous symptom and quality 
of life (QOL) concerns. Patient education is essential to support people in coping with 
multiple physical symptoms (anorexia, fatigue, dental issues, co-morbid conditions), 
psychological concerns (anxiety, depression), social concerns (finances, family burden, 
isolation), and spiritual issues (suffering, uncertainty) associated with advanced disease and 
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poor prognosis (Ferrell, Dow, Leigh, Gulasekaram, 1995; Hurria, et al., 2011). Placing the 
burden of a cancer diagnosis and the further encumbrance of oncology therapy (surgery, 
chemotherapy, or radiation) makes it difficult to distinguish the complexities surrounding 
nutritional risk in the older cancer patient undergoing therapy. However, identifying and 
treating nutritional risk before, during and after treatment may be crucial to positive clinical 
care outcomes.  
Literature Review Methods 
This review utilized Pub Med (using controlled vocabulary indexing of Medical 
Subject Headings [MeSH]), the Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), and Scopus electronic databases, and the PRISMA statement. 
Although a systematic review is most robust, for the purposes of this paper, a 
systematized review was used, as it is more appropriate for student work and single 
author efforts. The systematized review presents the same actions yet it does not include 
processes to establish inter-rater reliability within the literature review, as it is executed 
by one person only. This does make the analysis less reliable or comprehensive than a 
systematic review and there is a greater chance of study selection or exclusion bias (Grant 
& Booth, 2009). Multiple inclusion and exclusion criteria were applied as described 
below. The search was restricted to English language articles published between January 
of 2000 and March of 2015 and those related to humans. Posters, abstracts and oral 
abstracts were excluded. Studies addressing the nutritional risk, functional decline, and 
treatment reduction due to nutritional risk of the older cancer patient were included. 
Studies focusing on specific therapies, surgical interventions or younger populations were 
excluded. Standardized search terms were used when possible. Key words included 
geriatric, older adult, older, cancer, patient, nutrition, malnutrition, nutritional risk, 
nutritional assessment, QOL and therapy (Figure1). 
8 
 
Figure 1 
Standardized Definitions of Search Terms 
 
MeSH Term Year Introduced Definition 
 
Older Adult 
 
Not Identified 
 
Having greater age than 65 years 
 
Older 
 
Not Identified 
 
Having greater age than something or someone 
else 
 
 
 
 
Cancer 
 
 
 
 
400 B.C 
 
 
 
 
A malignant and invasive growth or tumor, 
especially one originating in epithelium, tending to 
recur after excision and to metastasize to other sites 
 
Patient 
 
Not Identified 
 
A person who is under medical care or treatment 
 
Nutrition 
 
1375-1425 
 
The act or process of nourishing or of being 
nourished 
Nutritional Risk Not Identified Not defined 
 
Malnutrition 
 
1950’s 
 
Lack of proper nutrition; inadequate or 
unbalanced nutrition 
 
Nutritional 
Assessment 
 
Not Identified 
 
Not defined 
 
Quality of Life 
 
  Not Identified 
 
  The standard of health, comfort, and happiness                
experienced by an individual or group. 
 
Therapy 
 
Not Identified 
 
The treatment of disease or disorders, as by some 
remedial, rehabilitating, or curative process 
9 
 
 
A total of 1978 full-text articles were initially identified, including 53 retrieved from the reference 
lists of the articles identified. Of these, 16 articles were found to meet the inclusion criteria and used in 
this review (Figure 2). The current literature is replete on the issue of malnutrition in the older cancer 
patient. Along with the lack of an agreed-upon definition of nutritional risk, there is inconsistency in the 
interpretation of findings from the nutritional screening tools used. Furthermore, the nutritional screening 
tools used are utilized in a sparse and inconsistent manner. 
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Figure 2 
PRISMA Flow Diagram Representing Selection of Studies 
 
 
(Hutton, et al., 2015; Moher, Liberati, & Altman, 2009)
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Results 
The PRISMA statement calls for a four-step literature review procedure: 1) identification, 2) 
screening with duplicates and irrelevant content removed, 3) abstract review, and 4) full text article 
assessment for eligibility (Moher, Liberati, & Altman, 2009). The researcher screened titles, abstracts, and 
full-text items retrieved by the literature search. The choice for inclusion of an article in the sample was 
guided by the following principles: the article was written and published in English, included human cancer 
patients, the patients were older adults, were undergoing therapy, and there was a nutritional component to 
the article. 
The 16 research studies included in the systematized review are identified and described in Table 1. 
The first column of Table 1 lists the author(s), title, and the year of publication. The second column states 
the purpose and concepts of the study, while column three lists the key words. Column four examine 
methods, designs, measures and samples utilized. Column five discusses the study findings while Column 
six details strengths and weaknesses. The 16 selected research articles consisted of prospective, descriptive 
studies, and two were pilots and two were randomized controlled trials. Although several of the articles 
addressed more comprehensive assessments than mere nutritional screening, in keeping with the focus of 
interest, this review focuses on nutritional risks of the older patient involved in the studies. To describe each 
study, the following details were characterized: author, title, journal, year, purpose of study, key words, 
major concepts, funding sources, and strengths and weakness (demographics, sample size, study design, 
content). 
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Table 1 
Selected Research Articles 
 
Authors/Title/Journal Purpose/Concepts Key Words Design/Tools/n Findings Strengths/ Weaknesses 
Chen, H., et al. (2003). 
Can older patients tolerate 
chemotherapy? Cancer, 
97(4): 1107-1114 
Purpose: To identify 
predictors of toxicity 
from chemotherapy 
in older cancer 
patients 
 
Concepts: Examined 
barriers (such as poor 
nutritional intake) to 
older cancer pts 
receiving adequate 
treatment due 
functional decline 
Cancer Older 
Geriatric 
Assessment 
Therapy 
Design: 
Prospective 
Pilot Study 
 
Tools: 
Instrumental 
Activities of 
Daily Living 
(IADL), 
Geriatric 
Depression 
Scale (GDS), 
Charlson Co-
morbidity Index 
(CCI), 
Mini 
Nutritional 
Assessment 
(MNA-SF), 
Mini Mental 
Status Exam 
(MMSE), 
Functional 
Assessment of 
Cancer 
Therapy- 
General 
(FACT- G) 
 
(n = 37) 
Older cancer patients 
undergoing chemotherapy 
may experience toxicity but 
generally can tolerate it 
with limited impact on 
independence, co-
morbidity, and QOL levels. 
It is important to monitor 
these changes during 
geriatric oncology treatment 
Strengths: Encompasses 
non- traditional end 
points in outcome 
research of cancer 
treatment. 
 
Weaknesses: Small 
sample size (37) & short 
follow up (130 days) 
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Freyer, et al. (2005). 
Comprehensive geriatric 
assessment predicts 
tolerance to 
chemotherapy 
and survival in older 
patients with 
advanced ovarian 
cancer: a 
GINECO study. Annals of 
Oncology, 16: 1795-
1800 
Purpose: To better 
define standards of 
care in older patients 
with advanced 
ovarian cancer 
Concepts: Effort to 
predict chemo 
tolerance and 
morbidity by 
pretreatment 
assessment (such as 
nutritional 
assessment/BMI) 
Geriatric 
Assessment 
Older Patient 
Cancer 
Therapy 
Design: 
Prospective 
Clinical 
Trial 
 
Comprehensive 
Geriatric 
Assessment  
(CGA) 
 
 
 
   (n = 60) 
 
 
The CGA could predict 
severe toxicity and overall 
survival of older advanced 
ovarian carcinoma patients 
Strengths:  Simple 
parameters may be 
systematically assessed in 
pts, assisting MD to choose 
best treatment 
for pt. 
 
Weaknesses:  Lack of 
standardized geriatric 
assessment. Possible pt 
selection bias. 
Ravasco, P., Monteiro- 
Grillo, I., Vidal, P.M., 
Camilo, M.E. (2005). 
Impact of nutrition on 
outcome: a perspective 
randomized controlled 
trial in patients with 
head and neck cancer 
undergoing 
radiotherapy. Head and 
Neck: 659-668 
Purpose: To 
determine the effect 
of dietary counseling 
 
Concepts: 
Demonstrated better 
outcomes & OS by 
pre & post treatment 
nutritional 
assessment, 
education, 
intervention & 
monitoring 
Nutrition 
Patient 
Cancer 
Therapy 
Design: 
Prospective 
Randomized 
Controlled 
Trial 
 
Tools: Ottery’s 
Subjective 
Global 
Assessment, 
European 
Organization for 
the Research and 
Treatment of 
Cancer Quality 
of Life 
Questionnaire 
(EORTC 
QLQ- C30) 
 
(n=75) 
During radiation treatment, 
nutritional interventions 
positively influenced 
outcomes., and counseling 
was a similar/higher 
benefit; in the medium 
term, only counseling 
exerted a significant impact 
on patient outcomes 
 
Strengths:  1st  group to 
show that nutrition is a 
key determinant of QOL 
in pts with cancer 
 
Weaknesses:  Failed to 
mention cost or cost-
savings of intervention 
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Hurria, A., et al., 
(2007). Identifying 
vulnerable older adults 
with cancer: 
Integrating geriatric 
assessment into oncology 
practice. Geriatric 
Assessment in Oncology 
Practice, 55: 1604-1608 
Purpose: To integrate 
the principles of 
geriatric assessment 
into standard of care 
for older patients 
with cancer 
 
Concepts: 
Utilizing CGA 
to assess 
functional & 
nutritional status 
to establish 
vulnerabilities in 
older cancer pts, 
along with 
establishing 
guidelines for 
appropriate 
multidisciplinary 
referrals (such as 
dietician) 
Older 
Cancer 
Geriatric 
Assessment 
Design: 
Prospective 
Descriptive 
Study 
 
Tools: 
Abbreviated 
Comprehensiv
e Geriatric 
Assessment 
(aCGA) 
 
  (n = 245) 
The aCGA, self-administered 
questionnaire is feasible for use 
in the outpatient oncology 
setting and helped identify the 
needs of geriatric oncology 
patients. Prospective trials are 
needed to determine the 
effectiveness of the 
interventions offered 
Strengths: Introduction of a 
feasible geriatric tool 
identifying areas of 
vulnerability 
 
Weaknesses: Population 
not representative of 
general population. 
Questionnaire content 
may not be objective. No 
threshold determined for 
nutritional referral 
and effectiveness of 
interventions 
Stauder, R., Moser, 
K.Holxner, B., Sperner-
Unterweger, B., & 
Kemmler, G. (2010). Six 
independent domains are 
defined by geriatric 
assessment in elderly cancer 
patients. Clinical Reviews in 
Oncology/Hematology: 97-
105. 
 
Purpose: To assess 
geriatric assessment 
tools by 
determining the 
number of 
independent 
domains measured 
 
Concepts: Identified 
6 domains for GA in 
older cancer pts (6th 
domain is nutritional 
status) & 
Geriatric 
Older 
Cancer 
Patient 
Design: 
Prospective 
Descriptive 
Study 
 
Tools: WHO 
Performance 
Status, 
Karnofsky Index 
(KPS), 
Activities of 
Daily Living 
(ADL), 
Instrumental 
From the six domains 
described a basis for efficient 
application of the geriatric 
assessment instruments in 
older cancer patients is 
worked out. The classical 
instruments WHO and KI as 
well as the screening scores 
VES-13 and PPT, while 
capturing physical 
functioning well, fail to cover 
several other important GA 
domains 
 
Strengths: 
Feasibility of GA was 
presented 
 
Weaknesses: Evaluation 
of screening instruments 
not done. Done in Europe-
cost in the U.S? 
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determining the use 
of appropriate 
assessment 
instruments 
Activities of Daily 
Living (IADL), 
Timed Get Up and 
Go (GUG), 
Physical 
Performance Test 
(PPT), 
Vulnerable 
Older Survey 
(VES-13), 
Functional 
Assessment of 
Cancer 
Therapy 
General Scale 
(FACT-G) 
Geriatric 
Depression Scale 
(GDS), Mini 
Mental Status 
Examination 
(MMSE), 
Cumulative 
Illness Rating 
Scale for 
Geriatricians 
(CIRS-G), 
Charlson Co- 
morbidity 
Index (CCI) 
   (n = 78) 
 
Mudge, A.M., et al. 
(2011). Helping 
understand the nutritional 
gaps in the older: a 
prospective study of 
Purpose: To better 
understand patient- 
specific factors 
associated with poor 
intake to improve 
Nutritional 
Older 
Older 
Design: 
Prospective 
Cohort 
Study 
 
Inadequate nutritional intake 
is common, and patient 
factors contributing to poor 
intake should be considered 
Strengths: 
Nutritional intake was 
direct observational. 
Inadequate intake was 
explicitly defined. 
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patient factors associated 
with inadequate 
nutritional intake in older 
medical inpatients. 
Clinical Nutrition, 30: 
320-325 
nutritional 
interventions 
 
Concepts: Identified 
nutritional gaps in 
older pts. Stressed the 
need for/possible 
guidelines for 
nutritional education 
& interventions 
Tools: 
Body Mass 
Index 
(BMI), 
Mini 
Nutritional 
Assessment 
(MNA-SF), 
Activities of 
Daily Living 
(ADL) ported 
 
(n = 134) 
in designing nutritional 
interventions 
Variables and confounders 
multidisciplinary 
perspective with validated 
measures 
 
Weaknesses:  Small 
sample size (134). 
Estimates of adequate 
nutritional intake may be 
optimistic. Single site 
study 
Hurria, A., et al. 
(2011a). Implementing a 
geriatric assessment in 
cooperative group 
clinical cancer trials: 
CALBG 360401. 
Journal of Clinical 
Oncology, 29(10):1290- 
1296 
Purpose: The 
geriatric assessment 
can predict 
morbidity and 
mortality in older 
adults, but are not 
routinely measured 
in cancer clinical 
trials 
Concepts: Examined 
the feasibility of 
integration of CGA 
in cancer clinical 
trials for geriatrics 
 
Geriatric 
Assessment 
Cancer 
Design: 
Prospective 
Descriptive 
Cooperative 
Group Trial 
 
Tools: 
Comprehensive 
Geriatric 
Assessment 
 
  (n = 85) 
This brief, primarily self- 
administered geriatric 
assessment tool met the 
protocol specified criteria for 
inclusion in future 
cooperative group clinical 
trials 
 
Strengths:  Results may 
help to modify & develop 
CGA 
 
Weaknesses:  CGA may 
be too brief, missing 
subtle findings. May take 
too much time of 
MD/RN. Questionnaires 
were self-reported & may 
not be objective. Small 
sample size (85). Not 
representative of general 
population 
Hurria, A., et al. 
(2011b). Predicting 
chemotherapy toxicity in 
older adults with cancer: 
a prospective 
multicenter study. 
Journal 
of Clinical Oncology, 
Purpose: To examine 
the toxicity of this 
vulnerable population, 
and identify the gaps 
in detecting those at 
risk, and develop a 
schema for studying 
Therapy 
Older 
Cancer 
Design: 
Prospective 
Descriptive 
Multicenter Study  
 
Tools: Not 
reported 
 
A risk stratification schema 
can establish the risk of 
chemotherapy toxicity in 
older adults. Geriatric 
assessment variables 
independently predicted the 
risk of toxicity 
 
Strengths:  Study fills 
critical gaps in frailty 
predictors for older 
patients 
 
Weaknesses:  Only 
reported grade 3 to 5 
toxicities. Population may 
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29(25): 3457-3465 toxicity in the older 
adult 
 
Concepts: Study of 
older adults and 
factors affecting 
toxicity risk 
   (n = 500) have been too 
heterogeneous. Findings 
need external validation 
Isenring, E.A., Banks, 
M., Ferguson, M., & 
Bauer, J.D. (2012). 
Beyond malnutrition 
screening: appropriate 
methods to guide 
nutrition care for aged 
care residents. 
Academy of Nutrition 
and Dietetics, 112(3): 
376- 
381 
 
 
Purpose: To 
determine the 
concurrent validity 
of several 
malnutrition 
screening tools and 
anthropometric 
parameters against 
validated nutrition 
assessment tools in 
the long-term care 
setting 
 
Concepts: Stressed 
the importance of 
nutritional screening 
in older pts. 
Attempted to 
examine the 
appropriate 
screening 
instruments 
Nutritional 
screening 
Malnutrition 
Aged 
Nutrition 
 
 
 
 
Design: 
Prospective 
Cross-
Sectional 
Observational 
Study 
 
Tools: 
Malnutrition 
Universal 
Screening Tool 
(MUST), Mini 
Nutritional 
Assessment 
Short Form 
(MNA-SF), 
Simplified  
Nutritional 
Assessment 
Questionnaire 
(SNAQ), 
Subjective 
Global 
Assessment 
(SGA), Body 
Mass Index 
(BMI) 
   (n = 127) 
MST, MUST, MNA-SF, and 
the anthropometric screens 
corrected arm muscle area 
and calf circumference have 
acceptable concurrent 
validity compared with 
validated nutrition 
assessment tools and can be 
used to triage nutrition care 
in the 
long-term setting 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strengths:  Blinded 
research. Nutritional 
screens were 
randomized 
 
Weaknesses:  May 
have incorrect 
weighing of pts. 
Presence of 
malnutrition may have 
been underestimated 
due to population. 
Lack of standard tool 
makes classification 
difficult 
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Sourbeyran, P., et al. 
(2012). Predictors of 
early death risk in older 
patients treated with 
first-line chemotherapy 
for cancer. Journal of 
Clinical Oncology, 30: 
1829 
Purpose: Exploring 
the gap in choices 
for treating the 
older cancer 
patient. To assist 
MDs in selecting 
appropriate 
treatments via 
factors predicting 
early death after 
initiating treatment 
 
Concepts: 
Comparison of usual 
care in functional & 
nutritional 
management vs. 
use of validated 
tools in an effort to 
predict at-risk pts for 
early death in older 
pts on chemo 
Older 
Patient 
Therapy 
Cancer 
Design: 
Prospective 
Descriptive 
Study 
 
Tools: 
Abbreviated 
Comprehensiv
e Geriatric 
Assessment 
(aCGA), 
Activities of 
Daily Living 
(ADL), 
Instrumental 
Activities of 
Daily Living 
(IADL), 
Geriatric 
Depression 
Scale(GDS), 
Timed Get up 
and Go(GUG), 
Mini Nutritional 
Assessment 
(MNA-SF), 
Charlson Co-
morbidity Index 
(CCI) 
 
(n = 348) 
In patients greater than 70 
years of age with cancer, 
advanced disease, a low 
MNA-SF score, and poor 
mobility predicted early 
death. It is recommended that 
the MNA-SF and GUG, 
performed by a trained nurse, 
be maintained as a part of 
routine pretreatment  work 
up in these patients to 
identify at- risk patients and 
to inform the decision-
making process of 
chemotherapy 
 
 
Strengths:  Broadens the 
scope for a standardized 
geriatric assessment. 
Study indicated 
prognostic power of 
MNA-SF in identification 
for 
early mortality 
 
Weaknesses:  No 
standardized tool for 
assessment. Different 
thresholds for 
intervention. Population 
may have been too 
heterogeneous 
Hoppe, S., et al. (2013). 
Functional decline in older 
patients with cancer 
receiving first-line 
Purpose: To 
determine factors 
associated with early 
functional decline in 
Older 
Cancer 
Therapy 
Design: 
Prospective 
Descriptive 
Study 
 
There were associations 
between baseline depression, 
instrumental dependencies, and 
early functional decline during 
chemotherapy for older 
Strengths:  Specific 
consideration for 
definition of functional 
decline in older patients 
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chemotherapy. Journal of 
Clinical Oncology, 1(31): 
3877-3882  
first-line therapy in 
older patients 
 
Concepts: The use 
of validated tools 
pre/during/post 
chemo to 
evaluate/predict/ 
prevent functional 
and nutritional 
decline 
Tools: Activities 
of Daily Living 
(ADL), 
Instrumental 
Activities of 
Daily Living 
(IADL), 
Comprehensive 
Geriatric 
Assessment 
(CGA), Mini 
Nutritional 
Assessment 
(MNA-SF), 
Mini- Mental 
State 
Examination 
(MMSE), 
Geriatric 
Depression 
Scale (GDS), 
MAX2 index 
 
(n = 364) 
patients.ADL should be 
sequentially evaluated early 
during treatment. Baseline 
evaluation of the GDS and the 
IADL may be proposed to 
anticipate this event 
 
Weaknesses: Almost 
18% of pts had to be 
excluded due to missing 
data. Unavailability of 
MD to assess pts. No 
descriptive analysis 
of targeted pt activity 
Muffly, L.S., et al. 
(2013). Pilot study of 
comprehensive 
geriatric assessment 
(CGA) in allogeneic 
transplant: CGA 
captures a high 
prevalence of 
vulnerabilities in older 
transplant recipients. 
ASBMT 19:429-434 
Purpose: Studies the 
gap in evaluating the 
older adult transplant 
patient 
 
Concepts: Use of 
GA (& nutritional 
markers) in  older 
Hematopoetic Cell 
Transplant (HCT) 
patients to predict/ 
prevent 
Geriatric 
Assessmen
t Older 
Design: 
Prospective 
Pilot Study 
 
Tools: 
Comprehen-
sive Geriatric 
Assessment 
(CGA) 
 
 (n = 228) 
CGA uncovers a substantial 
prevalence of 
undocumented impairments 
in functional status, frailty, 
disability, and mental health 
in older allogeneic HCT 
patients 
 
 
Strengths:  Results are 
highly reproducible. 
Biological age gave 
good definition 
 
Weaknesses:  Single 
center study. Treatment 
regimens/dosing not 
consistent. Need for 
standardized tools. 
Inconsistency in 
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vulnerabilities 
before transplant 
Interventions 
Chapman, A.E., Swartz, 
K., Schoppe, J., & 
Arenson, C. (2014). 
Development of a 
comprehensive 
multidisciplinary geriatric 
oncology center, the 
thomas jefferson 
university experience.  
Journal of Geriatric 
Oncology: 164- 
170 
Purpose: With the 
growth of the older 
population, we 
MUST determine the 
best assessment tools 
to examine this ever- 
growing population 
 
Concepts: Stressed 
importance  of GA 
in older pts in order 
to develop an 
individualized 
education & 
intervention plan 
(such as dietary 
“navigation”) 
Geriatric 
Cancer 
Design: 
Prospective 
Descriptive 
Pilot Study 
 
Tools: 
Comprehensiv
e Geriatric 
Assessment 
(CGA) 
 
(n = 211) 
Potential discordance trends 
were observed with EGOG 
score and assessment of 
Fit/Vulnerable/Frail due to 
limitations in the data the 
paper was not able to 
illustrate definitive 
correlations. Several 
challenges with the 
development of the clinic 
include patient- related 
issues, navigation, financial 
reimbursement, referral 
patterns, and coordination of 
care during office hours. The 
authors felt the they were 
able to 
establish a model for a 
comprehensive 
multidisciplinary geriatric 
oncology evaluation center 
in the setting of a university-
based cancer center 
 
Strengths:  Instituted use 
of pt navigator to assist 
with increasing data 
collection. Discussed 
territorial attitudes of 
MDs regarding referrals 
 
Weaknesses: Missing 
data. Self- reported 
questionnaires may not 
be objective. Self-reports 
by pts conflicted with 
MD reports 
Brugel, et al. (2014). 
Impact of 
comprehensive geriatric 
assessment on survival, 
function, and nutritional 
status in older patients 
with head and neck 
cancer; Protocol for a 
multicentre randomize 
controlled trial 
Purpose: To assess 
the impact of the 
CGA on overall 
survival, function, 
and nutritional status 
of older patients 
with head and neck 
cancer 
 
Concepts: Use of 
GA for all high-risk 
Geriatric 
Assessment 
Older 
Patient 
Design: 
Multicenter 
Randomized 
Controlled 
Study 
 
Tools: 
Comprehensiv
e Geriatric 
Assessment 
(CGA) 
The authors expected the 
CGA to have a direct 
clinical benefit on the 
management of older cancer 
patients. If the expectation is 
fulfilled, the trial could lead 
to modification of the 
management model for older 
cancer patients 
 
Strengths:   1st RCT 
evaluating the efficacy 
of the CGA in older 
cancer pts. Used 
validated tools only. 
Stressed need for multi- 
disciplinary approach to 
CGA. Nutritional 
consult should be 
standard of care. 
Adequate f/u times 
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(EGESOR). BMC 
Cancer, 14(427) 
older cancer pts 
(head & neck) by 
evaluating functional 
& nutritional 
status/needs to 
customize treatment 
& follow up needs/ 
issues 
 
  (n = 704) 
 
Weaknesses:  GA is time 
consuming & proof of lack 
of resources in many clinics 
& centers. May have had 
contamination between 
intervention and control pts 
Wakabayashi, H. & 
Sashika, H. (2014). 
Malnutrition is 
associated with poor 
rehabilitation outcomes 
in older inpatients with 
hospital associated 
reconditioning: A 
prospective cohort 
study. Journal of 
Rehabilitative Medicine, 
46: 277-282 
Purpose: To 
investigate the 
association between 
nutritional status and 
rehabilitation 
outcomes in older 
patients with 
hospital-related de- 
conditioning 
 
Concepts: Examined 
the prevalence of 
malnutrition in older 
inpatients & 
associated poor 
outcomes 
Malnutrition 
Older 
Design: 
Prospective 
Cohort 
Study 
 
Tools: Mini 
Nutritional 
Assessment 
(MNA-SF), 
Body Mass 
Index (BMI) 
 
  (n = 169) 
Most older inpatients with 
hospital-associated 
deconditioning are 
malnourished. Nutritional 
status, albumin, and chronic 
disease-related malnutrition 
are associated with poor 
rehabilitation outcomes in 
hospital-associated 
deconditioning 
 
Strengths:  Identified 
consistent gaps in 
nutritional assessment and 
wellness of patients 
 
Weaknesses: No validated 
criteria used in 
intervention guidelines. 
MNA-SF may 
underestimate inadequate 
intake. May have 
confounding factors 
between outcomes. 
Intervention 
inconsistently performed 
Kenis, C., Decoster, L., 
Ban Puyvelde, K., De 
Greve, J., Conings, G., 
Milisen, K., Flamaing, J., 
Lobelle, J.P., & Wildiers, 
H. (2014). Performance of 
two geriatric screening 
tools in older patients with 
cancer.  Journal of Clinical 
Oncology, 32(1) 
Purpose: To 
compare the 
diagnostic 
characteristics of 
two geriatric 
screening tools to 
identify patients with a 
geriatric risk of 
functional decline 
and overall survival 
 
Geriatric 
Older 
Patient 
Cancer 
Design: 
Prospective 
Multicenter 
Non- 
interventional 
Study 
 
Tools: G8, Triage 
Risk Screening 
Tool (TRST) 
 
  (n = 937) 
Both geriatric tools G8 and 
TRST (triage risk screening 
tool), are simple and useful 
instruments in older patients 
with cancer for identifying 
patients with a geriatric risk 
profile and have a strong 
prognostic value for 
functional decline and 
overall survival 
Strengths:  Use of (2) 
highly sensitive and easily 
used CA tools with strong 
prognostic factors for 
functional decline. Good 
time f/u points 
 
Weaknesses:  Could 
not define geriatric risk 
profile 
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Concepts: 
Comparison of 
Triage Risk 
Screening Tool 
(TRST) & G8 to 
determine the 
feasibility & most 
effective tool in GA 
of older cancer pts 
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Demographic Representation 
Thirteen of the 16 studies reviewed identified populations of > 65 years of age, with 
the other 2 including those > 50 years, which was acceptable to the population being 
examined, due to the content of the study. The median age of participants  in all articles was 
72.5 years of age. 
Types of Instrumentation and Measurement 
Medical, nursing, psychological, and social work validated measures and tools were 
used in the selected 16 studies examining functional and nutritional well-being and risk.   
Tools examining risk(s) of functional and nutrition, such as the Comprehensive Geriatric 
Assessment (CGA), Abbreviated Geriatric Assessment (aCGA), Activities of Daily Living 
(ADL), Instrumental Activities of Daily Living (IADL), Mini Nutritional Assessment Short 
Form (MNA-SF), Nutritional Risk Index (NRI).Malnutrition Screening Tool (MST), 
Malnutrition Universal Screening Tool (MUST), Simplified Nutritional Assessment 
Questionnaire (SNAQ), Subjective Global Assessment of Nutritional Status (SGA), Body 
Mass Index (BMI), and the G8 Screening Tool were identified in the literature. For the 
purposes of this review, only the nutritional content of tools will be discussed. 
The use of surveys was evident in the selected literature and all papers employed 
previously published survey instruments (Figure 3). Instrumental Activities of Daily 
Living (IADL) were utilized by five studies (Chen, et al., 2003; Stauder, et al., 2010; 
Sourbeyran, et al., 2012 & Hoppe, et al., 2013). 
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Figure 3  
Tools and Scales 
 
Tools and Scales Studies Using Tool or Scale (n) 
Instrumental Activities of Daily Living 
(IADL) 
5 
Geriatric Depression Scale 4 
Charlson Co-morbidity Index 3 
Mini Nutritional Assessment (MNA-SF) 6 
Comprehensive Geriatric Assessment 8 
Functional Assessment of Cancer 
Therapy-General (FACT –G) 
2 
Mini Mental Status Examination 
(MMSE) 
3 
Activities of Daily Living 4 
Body Mass Index 3 
Subjective Global Assessment 2 
European Organization for the 
Research and Treatment of Cancer 
Quality of Life Questionnaire (EORTC 
QLQ-C30) 
1 
Karnofsky Index (KPS), Timed Get Up 
and Go (GUG), 
Physical Performance Test (PPT), 
Vulnerable Older Survey (VES-13), 
and Cumulative Illness Rating Scale 
for Geriatricians (CIRS-G). 
1 
Malnutrition Universal Screening Tool 
(MUST) and Simplified Nutritional 
Assessment 
Questionnaire (SNAQ). 
1 
G8 and Triage Risk Screening Tool 
(fTRST) 
2 
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Synthesis of the Literature 
Although most of the articles utilized more than one tool, the aCGA/CGA/SGA 
were most often employed (Freyer, et al., 2005; Hurria, et al., 2007; Hurria, et al,. 2011a; 
Sourbeyran, et al., 2012; Hoppe, et al., 2013; Muffly, et al., 2013; Chapman, et al., 2014 & 
Brugel, et al., 2014), followed by the MNA-SF (Chen, et al., 2003; Mudge, et al., 2011; 
Isenring, et al., 2012; Soubeyran, et al., 2012; Hoppe, et al., 2013 & Wakabayashi & 
Sashika, 2014). Freyer, et al. recruited 83 patients with the mean age of 76 and attempted to 
evaluate if the CGA could predict treatment tolerance and overall survival, and they 
concluded that it was successful. Hurria, et al. (2011a), advocated for the GA to identify 
vulnerable older adults with cancer. Their study consisted of 245 patients with a mean age 
of 76 and demonstrated that the GA is a valid tool for identifying vulnerable older cancer 
patients. These researchers emphasized the need to integrate the GA into daily oncology 
practice. In research by Hurria, et al. (2011b), the purpose of the study was to predict 
chemotherapy toxicity using the GA pre-treatment. There were 500 patients in this research 
with a mean age of 73. The results revealed the ability to predict chemotherapy toxicity in 
the older cancer patient. 
Soubeyran, et al. (2012) aimed to predict early death risk in older cancer patients 
using the aCGA. The study consisted of 348 participants with a mean age of 77.45. The 
research demonstrated that those patients over the age of 70 and a low MNA-SF and GUG 
(part of the aCGA) predicted an early death. They recommended the use of both tools by a 
trained nurse for routine pre-treatment evaluation. Hoppe, et al. (2013), measured functional 
decline in 364 older cancer patients receiving first- line chemotherapy. The tool of choice 
was the CGA (including the MNA-SF). Their research yielded the recommendation for the 
ADL, GDS, and IADL to all be conducted at baseline.  
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Muffly, et al., conducted a study using the CGA in transplant patients in an effort to 
capture the high prevalence of vulnerability in older transplant patients. There were 228 
patients over age 50. They found that the CGA uncovered a host of undocumented 
impairments in functional status, along with frailty, disability, and mental health concerns 
in this population.  
Chapman, et al. (2014), were striving to develop a comprehensive multidisciplinary 
geriatric oncology center. Realizing that the older population was growing rapidly, they 
noted the need to provide standardized care for this vulnerable group. Using the CGA, they 
identified interesting trends involving Eastern Cooperative Oncology Group (ECOG) scores 
and assessment of fitness and frailty, yet noted challenges in being able to develop a 
comprehensive clinic. In a study by Brugel, et al. (2014), the researchers examined the 
impact of the CGA on survival, function, and nutritional status in a multi-center randomized 
controlled study with patients aged 70 or older. The CGA was administered before 
treatment began. Findings were that the use of a CGA, improved survival, reduced 
admission rates, and enhanced functional status of this population. 
The MNA-SF was utilized by Chen, et al. (2003), in order to determine if older 
patients (n=37) can tolerate chemotherapy. The researchers concluded that older cancer 
patients undergoing therapy may experience some toxicities, yet generally tolerate treatment 
with limited impact. They recognized the importance of careful monitoring of these patients 
in order to maintain QOL and functional status. The MNA-SF was selected for this 
dissertation and the rationale is discussed in chapter 3 in the measures section 
Mudge, et al. (2011), realizing that malnutrition is an enormous problem in older 
adults, were striving to identify study gaps in nutrition of the older adult patient. There were 
134 participants in the study with a mean age of 80. The researchers concluded that 
inadequate nutritional intake is common, and a major factor contributing to this issue was a 
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lack of strong intervention design. Among various tools used, the MNA-SF revealed that 
31% of the patients were malnourished with an additional 37% at-risk for malnutrition. In a 
similar study, Isenring, et al.(2012), sought to examine appropriate methods to guide 
nutritional screening. There were 127 residents in the study, all over the age of 55. The 
investigator’s results showed that the MST, MUST, and MNA-SF were acceptable methods 
of nutritional assessment, and all useful in triaging cases for the older client.  
The research by Soubeyran, et al. (2012), (n=348) utilized several tools (among them 
the MNA-SF) to assist in predicting early death risk in older patients treated with first-line 
chemotherapy. The research documented that those patients over the age of 70, with cancer, 
advanced disease, and a low MNA-SF score predicted early death. They recommended the 
MNA-SF and GUG be administered by a trained nurse as part of the routine pre-treatment 
work up. Hoppe, et al. (2013), studied the functional decline in older cancer patients 
receiving first-line chemotherapy. There were 364 participants in this study who were aged 
70 or above. The results showed association between depression, IADLs, low MNA-SF, and 
functional decline. Wakabayashi & Sashika (2014) evaluated malnutrition with poor 
rehabilitation outcomes in older hospital patients. The study consisted of 187 patients who 
were aged 65 and over. Conclusions were that the MNA-SF and BMI were adequate tools to 
measure for malnutrition, and 87.6% of the patients were determined to be malnourished. 
Although several other tools were used to measure nutritional risk, each of the 
studies showed the MNA-SF to be a valid, acceptable tool for which to measure 
nutritional risk. The aCGA/CGA/SGA were more comprehensive, yet very time 
consuming and deemed not cost effective in the clinical setting. The MNA-SF was short, 
succinct, and easy to use.  
Of all the literature reviewed, it is interesting to note that all the studies dealt with 
the older adult cancer patients, and some assessed QOL scores or psychological 
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dimensions, while others assessed only physical aspects, such as whether the patient was 
on chemotherapy (what drugs were used, weight loss). Most studies recognized BMI as 
an important risk factor, therefore, there is very strong agreement about this. However, 
across the studies there was great variability in terms of what other concepts or variables 
were included. All the studies recognized nutritional assessment as important and that 
older adults are at higher risk. They also focused on the time of active treatment as 
particular risk.   
Discussion 
Studies reviewed show that severe malnutrition and weight loss play a significant role 
in one of five cancer deaths, yet nutrition is often an afterthought in the healthcare arena. 
Identification of nutritional risk and treatment of nutrition-related symptoms have been 
shown to stabilize or reverse weight loss in 50-88% of oncology patients (NCI, 2016). At the 
time of diagnosis, up to one fourth of patients are suffering anorexia, and most treatments 
bring with them additional side effects such as nausea, vomiting, and diarrhea. Older patients 
deal on a daily basis with co-morbidities, malabsorption, dental and financial issues.  
To make the right treatment decisions for older patients with cancer, an approach 
involving a CGA is advocated in several studies (Freyer, et al.; Hurria, et al; Hoppe, et al.; 
Muffly, et al.; and Brugel, et al., 2014).  Older patients are more likely than their younger 
counterparts to present with functional dependence, co-morbidity, polypharmacy, 
malnutrition, cognitive dysfunction, and depression. It has been shown that a routine 
clinical evaluation including assessment of performance status does not capture the full 
range of problems these patients may have (Sourbeyran et al., 2012). In addition to 
identifying remediable conditions influencing treatment, CGA is thought to be helpful in 
establishing treatment goals (SIOG, 2015). The CGA is a mixture of validated screening 
tools (several different models of the CGA exist), such as G8, ECOG, fTRST, VES-13, 
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ADL, IADL, MMSE, GDS, MNA-SF, GUG, CIRS-G, ACE 27, MAX2, and the. QLQ-
C30. The validity of CGA assessment questionnaires to predict outcome and adverse events 
during the management of the older patients with cancer is now established (Hurria, et al., 
2011a). Yet a comprehensive CGA is often not feasible in all older patients with cancer 
(SIOG, 2015) and although it has a nutritional component, its aim is to assess for frailty in 
the older adult patient population. It has been often documented that it is time-consuming 
and resource excessive (SIOG, 2015).  
Investigators suggest that patients could be first screened with the MNA-SF (or the 
MNA-SF) before considering the more comprehensive CGA. The patient information 
needed to assess for nutritional risk is easily collected utilizing the MNA-SF. The MNA-SF 
is the most widely used tool for patients 65 and older, a highly sensitive and specific (98 and 
100%, respectively), validated and reliable nutrition screening and assessment instrument 
that can identify geriatric patients who are malnourished or at risk of malnutrition. Studies 
have demonstrated internal consistency to range from 0.81 to 0.89 (Kaiser, et al., 2011). It is 
recommended by national and international clinical and scientific organizations and has 
been validated in over 400 studies (Kondrup, et al., 2003; Salva, et al., 2004). The MNA-SF 
was developed nearly 20 years ago and is the most well validated nutrition screening tool 
for the older patient.  
Originally comprised of 18 questions, the current MNA-SF now consists of six 
questions and streamlines the screening process. The current MNA-SF retains the validity 
and accuracy of the original MNA-SF in identifying older adults who are malnourished or 
at-risk of malnutrition (Rubenstein, et al., 2001). The revised MNA-SF Short Form (MNA-
SF) (with a sensitivity of 96% and specificity of 98%) makes the link to intervention easier 
and quicker (usually taking less than five minutes to complete), and is now the preferred 
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form of the MNA-SF for clinical use (Rubenstein, et al., 2001). It can be used in a wide 
variety of settings, requires no special training, no lab data, and is available in 24 languages.  
The MNA-SF targets the frail older and at-risk geriatric population and identifies the 
malnourished so intervention can begin immediately. It also identifies at-risk persons before 
weight loss occurs and serum protein levels fall, and facilitates earlier intervention when 
response is most successful (Delacorte, et al., 2004). The MNA-SF identifies at-risk persons 
before other validated nutrition screening tools do (Bauer, et al., 2005), and also those who 
may respond to treatment or may have poor outcomes. The tool not only detects people who 
are at nutritional risk, but allows healthcare professionals to target interventions to specific 
causes of malnutrition (Gregorio, et al., 2003). 
Implications for Future Studies 
Current studies do not support the assumption that older patients are unable to 
undergo cancer therapy. Certainly, they suffer more co-morbid conditions, but this does not 
support exclusion from treatments such as chemotherapy or radiation or participation in 
clinical trials. Future research should evaluate aggressive nutritional risk screening in the 
older cancer patient before, during, and post-treatment. The outcome measures need to be 
comprehensive enough to capture clinical, psychological, social, spiritual, and QOL aspects 
of each patient’s life with robust and validated tools. 
Conclusion 
Advanced healthcare professionals can provide timely, comprehensive, nutritional 
assessment and education to older cancer patients undergoing therapy. Gaps remain in the 
literature regarding how to identify nutritional risk in the older cancer adult undergoing 
therapy. While many tools are available, they are not utilized consistently. Additionally, 
few studies include older cancer patients.  
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Cancer treatments are increasingly being done in the outpatient setting, which 
makes it even more important for oncology professionals to monitor these individuals 
continuously, which is not being done. Thus, research should be conducted at baseline in 
the outpatient setting.  Nutritional risk screening should be done as an interdisciplinary, 
ongoing process throughout the cancer trajectory. 
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Chapter 3. Methodology 
 The purpose of chapter 3 includes an overview of the study design, sample and 
population, description of measures used in the proposed study, research methods, and 
statistical analysis plan. In addition, the chapter will include an overview of the plan for 
human subject’s protection and ethical considerations. Finally, the chapter will close with a 
summary of the overall timeline for the study. 
Study Purpose 
The overall purpose of this study describes the nutritional risk of cancer patients 65 
years and older who are receiving systemic treatments via Phase I clinical trials. It describes 
the relationship between nutritional risk and the four domains of QOL (physical, social, 
emotional, and functional). 
Hypotheses 
1) Nutritional risk is associated with demographic and disease/treatment variables of 
age, gender, and time since diagnosis and treatments. 
2) Nutritional risk is associated with QOL including physical, emotional, social, and 
functional well-being and overall QOL. 
Conceptual Model  
This study was guided conceptually by an adapted version of the City of Hope QOL 
model that addresses nutritional risk in older cancer patients, focusing on the four key 
domains of QOL (Ferrell, Dow, Leigh, Gulasekaram, 1995). The World Health Organization 
defines QOL as ‘‘individuals’ perceptions of their position in life in the context of the culture 
and value system in which they live and in relation to their goals, standards, and concerns’’ 
(Revicki et al., 2000). The definition includes six broad domains: physical health, 
psychological state, levels of independence, social relationships, environmental features, and 
spiritual concerns. This broad definition includes aspects such as the environment (food and 
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nutrition, etc.) not usually included in the perspective of QOL for cancer patients. This 
conceptual framework of the City of Hope QOL Model is defined as consisting of four 
dimensions or domains (Figure 4). Physical well-being issues are focused on common disease 
or treatment- related symptoms that may impact nutritional status and/or put patients at high-
risk for malnutrition. These include pain, fatigue, and nausea. Emotional well-being issues 
include anxiety, depression, fear of recurrence and coping. Social well-being domain issues 
include family distress, social support, communication, and isolation, all of which can impact 
patient’s ability to access foods and nutrition. Functional well-being concerns ability to work, 
enjoyment, sleep disturbance, and overall QOL. The City of Hope QOL model acknowledges 
that a person’s QOL is 1) subjective, 2) based on the self-report, 3) always changing and 
dynamic, and 4) a multidimensional concept (Ferrell, Dow, Leigh, Gulasekaram, 1995). This 
study does measure physical, emotional, social, and functional well-being consistent with the 
City of Hope QOL Model.  
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Figure 4  
City of Hope QOL Model Applied to Nutritional Risk in Older Cancer Patients 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Ferrell, Dow, Leigh, Ly, & Gulasekaram, 1995) 
  
Physical Well Being 
Fatigue 
Nausea & vomiting 
Function 
Pain 
Side effects of treatment 
 
 
Social Well Being 
Closeness to family/friends 
Support from family/friends 
Family acceptance of illness 
Communication 
  
Psychological Well Being 
Sadness  
Coping 
Hope 
Nervousness 
Worry about dying 
Worry that condition will 
worsen 
 
 
Functional Well Being 
Ability to work 
Fulfillment of work 
Enjoyment of life 
Acceptance of illness 
Sleep disturbance 
Enjoyment 
Contentment with QOL 
QOL 
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Overall Research Design 
 The study was a retrospective, descriptive, cross-sectional, descriptive correlational 
survey study done at a single point in time. Baseline assessment was done only.  
Sample and Setting 
The sample consisted of solid tumor cancer patients receiving disease-directed 
therapies in Phase I clinical trials. Patients were enrolled in a National Cancer Institute 
(NCI)-funded R01 that evaluated the efficacy of a palliative care intervention. The sample 
provided patients for this dissertation. Inclusion criteria are as follows: 
 Patients diagnosed with solid tumors who are eligible for participation in Phase I 
clinical trials of investigational cancer therapies. 
 Patients who have signed an informed consent for participation in Phase I clinical 
trials. 
 Age 65 years or over. 
 Able to read or understand English – this is included because the intervention and 
study materials (including outcome measures) are only in English.  
 Ability to read at a fifth grade level and/or understand the study protocol 
requirements, and provide written informed consent. 
Exclusion criteria includes patients diagnosed with hematologic (as a population distinct from 
solid tumors and different trials) cancers. 
 Participants were enrolled in the ambulatory clinic of an NCI-designated comprehensive 
cancer center in Southern California. The study utilized a cross-sectional sampling of eligible 
patients enrolled in the Randomized Controlled Trial (RCT). All solid tumor patients who 
have signed an informed consent for participation in a Phase I clinical trial and who also meet 
the inclusion criteria for this study were identified by their treating oncologist who then 
notified the investigator, the PhD candidate (PhDc), for screening. After eligibility screening, 
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the investigator, contacted eligible patients and explained the study purpose, answer any 
questions, and ascertain interest in participation.  If the patient agrees, written informed 
consent was obtained (Appendix A).  Accrual began March 3, 2017, and continued through 
the month of February 2019. 
Measures 
 The Mini Nutritional Assessment Short Form (The MNA-SF) (Appendix B) - is a 
reliable and valid measure for nutritional risk in older cancer patients. The patient 
information needed to assess for nutritional risk is easily collected utilizing the MNA-SF as it 
gathers all the pertinent data in which to assess for nutritional risk in the older adult cancer 
patient. The MNA-SF is the most widely used tool in older adults, and is a highly sensitive 
and specific, validated and reliable nutrition screening and assessment instrument that can 
identify geriatric patients age 65 and above who are malnourished or at-risk of malnutrition. 
Validity was established confirming the six items of the MNA-SF scores with other measures 
of nutritional status (such as BMI and anthropometric parameters) with correlations of .83 to 
.86 (Kaiser, et al., 2009). It is recommended by national and international clinical and 
scientific organizations and has been validated in over 400 studies (Kondrup, et al., 2003; 
Salva, et al., 2004). The revised MNA-SF makes the link to intervention easier and quicker 
(usually taking less than five minutes to complete), and is now the preferred form of the 
MNA-SF for clinical use (Rubenstein, et al., 2001). It can be used in a wide variety of 
settings, requires no special training, no labs, and is available in 24 languages. It also 
identifies at-risk persons before weight loss occurs and serum protein levels fall, and 
facilitates earlier intervention when response is most successful (Delacorte, et al., 2004). A 
representative from Nestle granted approval for use of the eight-item instrument 
 (Appendix C).  
Other measures used in this study included the following: 
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Demographic and Disease Tool (Appendix D) – This tool was developed by the RO1 
investigators (Ferrell, et al., (2019) and used to compile information on each patient at 
baseline. It includes information on age, ethnicity, education level, religious affiliation, 
marital status, living situation, employment, annual income, past treatment, co-morbidities, 
social support, functional status, cancer diagnosis, and time since diagnosis. 
Functional Assessment of Cancer Therapy-General (FACT-G) (Appendix E) – The FACT-G 
(Version 4), created by Cella, et al. (1993), is a cancer specific version of the FACIT 
(Functional Assessment of Chronic Illness Therapy) Measurement System. It contains a 27-
item compilation of general questions divided into four QOL domains: Physical Well-Being, 
Emotional Well-Being, Social/Family Well-Being and Functional Well-Being. For each item, 
the respondent indicates on a 5-point Likert scale (0=not at all; 5=very much) how true each 
statement is for him/her during the past seven days.  The FACT-G yields a total score for the 
overall QOL as well as subscale scores. Internal consistency and reliability measures revealed 
a Cronbach’s coefficient alpha of 0.89 for the total FACT-G. Coefficients for the four 
subscales are as follows: 0.82 for physical well-being, 0.74 for emotional well-being, 0.69 for 
social well-being and 0.80 for functional well-being. Validity of the FACT-G was established 
by Cella, et al. (1993), using ANOVA of scores from four groups of patients/survivors. 
Comparisons demonstrated construct validity for the FACT-G Total Score and four subscales 
of <.05 to <.001.  
Timeline 
 Data in the parent study (the RO1 focused on Phase I clinical trial patients), was 
collected at baseline and at four, twelve, 16, and 24 weeks from September, 2014 to March, 
2019. This study began accrual in February 2017, to February, 2019. Only baseline data was 
used since the purpose of this study describes the nutritional risk of cancer patients 65 years 
and older who are beginning systemic treatments via Phase I clinical trials. 
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Data Analysis 
Procedures 
 Demographic data was collected for eligible patients at baseline. The MNA-SF and 
FACT-G tools were also administered at baseline (Table 2).  
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Table 2 
Measures and Tools 
 
 
Measures/Tools 
 
Reliability 
 
Validity 
 
Sensitivity 
 
Specificity 
 
Demographic and 
Disease Tool 
 
 
 
 
 
 
 
The tool is completed 
via chart audit by the 
PhDc with any questions 
clarified with the patient 
and/or primary 
physician 
 
The tool is limited to 
demographic variables  
 
The tool has been used 
extensively by City of 
Hope investigators and 
designed for the oncology 
population 
 
The tool was designed 
specific to the oncology 
population with items 10-14 
specific to oncology 
treatment and item 15 to 
capture comorbidities of 
specific interest for older 
patients 
 
FACT-G 
 
 
 
 
 
 
 
 
Cronbach’s alpha .89 for 
total tool and .69 -.82 
for the four subscales 
 
Construct validity established 
by comparison of patient 
groups for scale and subscales 
by ANOVA (p < .05) 
 
The FACT-G is sensitive 
to variables of interest for 
this study including 
physical, social, emotional 
and functional items which 
would be related to 
nutritional risk 
 
The FACT-G is the cancer-
specific tool within the 
FACIT measurement library 
 
MNA-SF 
 
 
 
 
 
Internal consistency for 
the 6 items have been 
established at .81 - .89 
 
Validity was established 
through concurrent measures  
(BMI and anthropometrics) at 
.83 - .86 
 
The 6 items reflect 
variables of importance in 
oncology 
 
The items reflect concerns 
of significance to older 
cancer patients in treatment 
(e.g. food intake, weight 
loss, mobility, stress and 
sadness) 
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The City of Hope Biostatistics Core designed and implemented a relational data 
management system that serves three functions: a tracking function (screening, consent, 
enrollment, data collection and tracking accrual), a reminder function, and a data entry and 
storage function. Queries were available to address data validity and integrity, data collection 
inconsistency, data inaccuracy or incompleteness.   
Data packets which were scanned are designed using the Telescan system to minimize 
time and inherent error in keyed data entry. Completed instruments were numbered according 
to group, data point, and unique identification number.  The Principal Investigator, the PhDc 
kept the list of subject names and identification numbers in a locked file cabinet.  Each 
completed instrument was numbered appropriately, copied, and the copies filed in a locked 
cabinet, while originals were transferred for data entry and analysis.  Data scanned from 
Telescan forms were stored in the SQL database on a secured network. Data were read using 
Statistical Analysis Software (SAS). All multi-item instruments were scored according to the 
scoring manuals or other formal scoring rules as appropriate.   
Demographic data were analyzed using descriptive statistics (means, ranges, and 
percentiles). Hypothesis 1, is Nutritional risk is associated with demographic and disease 
variables of age, gender, race, cancer diagnosis, and time since diagnosis. Data for this 
hypothesis was analyzed using multiple regression to determine factors influencing MNA-SF 
scores. Hypothesis 2, is nutritional risk associated with QOL including physical, emotional, 
social, and functional well-being and overall QOL. This hypothesis was also analyzed 
through multiple regression using FACT-G Total and Subscale Scores and MNA-SF Total 
Score.  
Human Subjects 
1.  Risks To The Subjects 
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1a)  Characteristics, Inclusion of Women, Minorities and Children - The sample 
included older adult patients with solid tumors who are participating in Phase I clinical trials.  
Additional effort was made to recruit minorities.  Children were not included as the study 
was limited to men and women 21 years and older with a solid tumor diagnosis. 
1b)  Sources of Research Materials - All data collection was limited to written surveys 
used widely in cancer research and selected to minimize subject burden. Privacy was 
provided for all data collection. 
1c)  Potential Risks – All contacts with the patient was arranged at the patient’s 
convenience and in the setting preferred (clinic or home visit).  The only potential risk 
involved was emotional distress in discussing their symptoms and QOL needs.  The time 
required for data collection was approximately 30 minutes. In any situation where a patient 
was experiencing uncontrolled symptoms, the PhDc contacted the treating oncologist 
immediately.  
2.  Adequacy of Protection Against Risks 
2a) Recruitment and Informed Consent – Patients were identified through selection of 
eligible patients through the treating oncologist.  Potential subjects had their first contact with 
the PhDc through identification by the treating oncologist. The PhDc and oncologists 
ascertained patient interest in the study. The PhDc and oncologists verified eligibility and 
contacted the patient in the clinic or by phone.  The PhDc informed the patient about the 
nature of their participation and the duration of the study. The PhDc informed patients of all 
data collection methods, the time required, and potential risks. Patients had the opportunity to 
ask questions, and were free to withdraw from the study at any time. Patients were also 
provided the opportunity to refuse to answer any specific questions. The PhDc obtained 
written consent, (Appendix A) approved by COH, from all subjects.  
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2b)  Protection Against Risks – Participation was voluntary and all data were kept 
anonymous and confidential.  Subjects’ names were not included on data instruments and all 
data were maintained in the PhDc’s locked files. 
3.  Potential Benefits of the Proposed Research to the Subjects and Others 
3a) Included recognition of nutritional risks, QOL concerns, and symptoms.   
4.  Importance of the Knowledge to be Gained – Knowledge to be gained from this study 
may potentially benefit present and future cancer patients by addressing nutritional risks, 
QOL concerns and symptoms. The knowledge from this study will also likely be applicable 
to other patients receiving active treatment for advanced cancers.   
5. Data and Safety Monitoring Plan – This protocol was approved by the COH Cancer 
Protocol Research Monitoring Committee (CPRMC), Data Safety and Monitoring Board 
(DSMB), and the Institutional Review Board (IRB) of both COH and the UoH.  Institutional 
procedures for quality control, data management and analysis was obtained prior to patient 
recruitment. The PhDc password protected the database containing the sampling frame of 
potentially eligible patients. The outcome data, process data, and quality control data was 
stored with a coded number, in a locked cabinet. No patient identifiers were listed in the 
database and only numerical identifiers were used.  
Potential Limitations 
 Limitations include a relatively small sample size at one facility, which is oncology-
focused. It is a convenience sample which is part of a larger study of Phase I clinical trial 
patients. Participant recruitment was limited due to little to no incentive to complete the 
survey. Generalizability is limited to the sample and not other various populations for 
replication.  
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Summary of Chapter 3 
Despite the current evidence, strategies to assess and identify patients at risk for 
malnutrition are not fully integrated into routine oncology care. Possible causes for this 
include the following: 1) the definition of nutritional risk is poorly understood (Isenring & 
Elia, 2015; van Bokhorst-van der Schueren, et al., 2014), and 2) there is a deficiency in tools 
to assess nutritional risk that is relevant to older cancer patients. It is our responsibility as 
healthcare professionals to provide timely, comprehensive, nutritional assessment and 
education to our older cancer patients undergoing therapy - a vulnerable population. Cancer 
treatments are increasingly being done in the outpatient setting, which makes it even more 
important to monitor these individuals continuously. Nutritional risk screening should be 
done as an interdisciplinary, ongoing process throughout the cancer trajectory. In this study 
the PhDc described the methodology of a study to describe the nutritional risk of older cancer 
patients (65 years and older) who are receiving systemic treatments via Phase I clinical trials. 
The PhDc aimed to determine the utility of the MNA-SF as a valid nutritional risk 
assessment, and seeks to identify high-risk populations by assessing factors that predict 
malnutrition and weight loss in older cancer patients.  
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Chapter 4. Results 
 This chapter presents the results from the completed quantitative, descriptive study of 
cancer patients 65 and older undergoing systemic cancer treatments using a cross-sectional 
survey method. A discussion of the sample, data analysis and summary of the results is 
included. 
Research Approval and Site 
 This study was conducted in the Southern California area location at the City of Hope 
National Medical Center campus. The Institutional Review Board for the City of Hope 
approved the parent RO1 IRB reference # 13193/138023 (Appendix F) and an amendment to 
add the MNA-SF as a nutritional aspect and focus of this dissertation.  The Institutional 
Review Board for the University of Hawaii approved this retrospective study using the RO1 
data in January of 2019 Reference # 2018-01098 (Appendix G). Data included in this study 
were collected from February 2017 to February 2019.   
Sample 
 Description of Participants 
The sample consisted of patients 65 years or older with solid tumor cancers receiving 
disease-directed therapies in Phase I clinical trials. Patients were enrolled in a National 
Cancer Institute (NCI)-funded R01 that evaluated the efficacy of a palliative care 
intervention. The sample for this dissertation research consisted of a total of 73 patients. 
Inclusion criteria were as follows: 
 Patients diagnosed with solid tumors who were eligible for participation in Phase I 
clinical trials of investigational cancer therapies. 
 Patients who had signed an informed consent for participation in Phase I clinical 
trials. 
 Age 65 years or over. 
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 Able to read or understand English. This is included because the intervention and 
study materials (including outcome measures) were available only in English.  
 Ability to read at a fifth grade level and/or understand the study protocol 
requirements, and provide written informed consent. 
 The investigator used the data from the RO1 study to conduct a secondary analysis      
focused on the older patients and their nutritional needs.   
Results 
 Data Analysis Methods 
 Patient characteristics were summarized using mean, standard deviation, median and 
range for continuous data such as age, BMI, number of comorbidities, and all QOL scores. 
Categorical data were summarized using frequencies and percentages. QOL metrics from 
the FACT-G questionnaire were further detailed by individual questions within the 
questionnaire, and summarized by subscale and overall score. The MNA-SF questionnaire 
contained six questions, the detailed summary of which is provided along with the overall 
score. In addition, MNA-SF scores were examined in more detail with respect to several 
key patient characteristics.  
 The Pearson correlation coefficient was calculated to observe the strength and 
significance of the association between demographic variables as well as QOL metrics and 
the overall MNA-SF score obtained at baseline. Univariate and multivariate linear 
regression was then conducted to see how well the overall MNA-SF score could be 
predicted using age, BMI, gender, treatment (surgery, chemotherapy and radiation), the 
FACT-G overall score, and FACT-G subscales. Predictors included in the univariate 
analysis were entered into the multivariate model using the stepwise method. Variables 
were entered into the multivariate model if their corresponding p-value fell below the 
threshold of 0.15, and were retained in the model if the p-value remained below 0.10 once 
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combined with the remaining variables sustained in the previous step or iteration 
(Tabachnick & Fidell, 2018). Since the data used in this analysis involved baseline data 
only, the data completions rate was high (>99%), and occurrence of missing values in the 
data was infrequent. Thus, no imputations or interpolation was needed or done.  
 Baseline patient demographics and other characteristics are summarized in Table 3, 
and disease and treatment variables are summarized in Table 4. QOL metrics from the 
FACT-G questionnaire were further detailed by individual questions within the 
questionnaire, and summarized by subscale as well overall score in Table 5. Responses to 
the six questions from the MNA-SF questionnaire, as well as the overall MNA-SF 
summary score are reported in Table 6. Additional MNA-SF score distributions were 
examined with respect to patient age group, gender, BMI, race/ethnicity, and time since 
cancer diagnosis (Table 7). 
 Demographic Data 
 The demographics of the sample (n=73) are presented in Table 3. The average age 
was 71.4, and 53.4% of the participants were female. Over 76% were Caucasian with 23% 
were minorities. African Americans accounted for 2.7%, there were 8.2% Asian, Hispanics 
made up 8.2%, Native Americans plus “other race” accounted for 1.4%, and Native 
Hawaiian/Pacific Islander made up 2.7% of the population. The educational level yielded 
79.5% of college-educated subjects, and 34.2% were Protestant as the most common 
religious group. Sixty-nine percent (69.9%) were either married or partnered with 69% 
living with a spouse or child. Seventy-three percent (72.6%) were retired and 61.6% had a 
family income of greater than $50,000.  
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Table 3  
Patient Demographics 
Patient Characteristics 
 
n (%), mean(std) or 
median (min, max) 
Age (y) 
  
71.4 (5.1) 
70 (65, 90) 
Gender  
Female 39 (53.4%) 
Male 34 (46.6%) 
Race  
African American 2 (2.7%) 
Asian 6 (8.2%) 
Caucasian 56 (76.7%) 
Hispanic Latino 6 (8.2%) 
Native American plus Other Race 1 (1.4%) 
Native Haw/Pacific Islander 2 (2.7%) 
Education  
Did not complete High School 1 (1.4%) 
High School 7 (9.6%) 
College 58 (79.5%) 
Graduate/Professional School 6 (8.2%) 
Not Reported 1 (1.4%) 
Religion  
None 12 (16.4%) 
Catholic 20 (27.4%) 
Jewish 11 (15.1%) 
Protestant 25 (34.2%) 
Other 5 (6.8%) 
Marital Status  
Never married 3 (4.1%) 
Married or partnered 51 (69.9%) 
Divorced 10 (13.7%) 
Widowed 9 (12.3%) 
Other members  
Alone 14 (19.7%) 
Children/Parents/Relatives 5 (6.8%) 
Friend 3 (4.2%) 
Spouse/Children 
          Other                                                                                      
49 (69.0%) 
2 (0.3%) 
Employment Status  
Employed full time 7 (9.6%) 
Employed part time 8 (11.0%) 
Homemaker 2 (2.7%) 
Retired 53 (72.6%) 
Unemployed 3 (4.1%) 
Family Income  
$20,001 to $30,000 1 (1.4%) 
$40,001 to $50,000 15 (20.5%) 
Greater than $50,000 45 (61.6%) 
          Not Reported 12 (16.4%) 
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Disease and Treatment Characteristics  
 
 Disease and treatment characteristics are described in Table 4. The sample included 
several types of solid tumors with ovarian followed by colon as the most predominant 
cancers. 
  In terms of year of cancer diagnosis, 19.2% were diagnosed in 2010 or earlier, with 
37.9% being diagnosed from 2011-2015. Thus, the majority of these patients were 
diagnosed eight or more years ago which is representative of patients who are now being 
placed on a Phase I clinical trials. Most patients had previous surgery and chemotherapy 
and approximately 43% had previous radiation therapy.  
 Only 21.9% had tried alternative therapies. The average number of co-morbidities 
was 2.2. Over 35% of the participants had an advanced care directive and only 39.7% had 
named a proxy decision maker. The 60 patients reporting on code status were equally 
divided between having a Do Not Resuscitate (DNR) order and having a full code status. 
Only 11% had been referred to the Pain and Palliative Care service and only 56.2% had 
been referred to Social Work.  
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Table 4 
Disease and Treatment Characteristics 
 
Disease/Treatment Characteristics n (%), mean(std) or 
median(min, max) 
Type of Cancer  
Ovarian 11 (15.1%) 
Colon 9 (12.3%) 
Lung 8 (11.0%) 
Prostate 8 (11.0%) 
Bladder 4 (5.5%) 
Breast 4 (5.5%) 
Pancreatic 4 (5.5%) 
Rectal 3 (4.1%) 
Other 22 (30.1%) 
Year of Cancer Diagnosis  
2010 or earlier 14 (19.2%) 
2011-2015 35 (37.9%) 
2016 10 (13.7%) 
2017 13 (17.8%) 
2018 1 (1.4%) 
Current/Previous Surgical Procedure 59 (80.8%) 
Current/Previous Chemotherapy 59 (80.8%) 
Current and Previous Radiation Therapy 32 (43.8%) 
Tried Alternative Therapies 16 (21.9%) 
Number of Comorbidities 
                            
2.2 (1.3) 
2 (0, 5) 
Advanced care directive  
Yes 26 (35.6%) 
No 47 (64.4%) 
Proxy decision maker  
Yes 29 (39.7%) 
No 44 (60.3%) 
Code Status  
DNR 30 (41.1%) 
Full Code 30 (41.1%) 
Not Reported 13 (17.8%) 
Referred to Pain/Palliative 8 (11.0%) 
Referred to Social Work 41 (56.2%) 
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Nutritional Risk and Demographic/Treatment Variables 
Hypothesis 1 was: Nutritional risk is associated with demographic and disease/treatment 
variables of age, gender, and time since diagnosis and treatments. To test this hypothesis, the 
Pearson correlation coefficient was calculated to show association between MNA-SF score 
and various demographic and clinical factors. These variables are described in Table 5 and 
the correlations are presented in Table 6. There is a very slight negative association between 
MNA-SF and age (r=-0.12), indicating that older patients tend to have slightly lower MNA-
SF scores. However, this is not a statistically significant result (p=0.3). There was very low 
or no association between MNA-SF score and gender, prior/current surgical treatment, 
prior/current chemotherapy, or radiation (r<0.1 for all). The largest association is seen with 
BMI, with ρ =0.47 (p<0.0001).  
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Table 5  
 MNA-SF Score Statistics by Demographic Variable Stratification 
 
 Demographic Variable MNA Total Score 
 n mean (std) median (min, max) 
Age group (y)    
   65-69 31 10.5 (1.9) 12 (5, 12) 
   70-74 22 8.8 (2.6) 8 (5, 14) 
   75-79 15 9.5 (2.0) 10 (6, 13) 
   80+ 5 9.8 (3.1) 11 (6, 13) 
Gender    
   Female 39 9.6 (2.4) 10 (5, 14) 
   Male 34 9.9 (2.2) 10.5 (6, 13) 
BMI    
   <18.5 (underweight) 5 5.8 (1.3) 5 (5, 8) 
   18.5-24.9 (normal wt) 41 9.5 (2.1) 9 (5, 13) 
   25.0-29.9 (overwt) 20 10.8 (1.7) 12 (7, 12) 
   30.0-34.9 (obese) 4 10 (3.6) 9.5 (7, 14) 
   ≥ 35 (morbidly obese) 3 12 (0) 12 (12,12) 
Years Since Dx    
   2010 or earlier 14 10.3 (2.4) 12 (5, 12) 
   2011-2015 35 9.6 (2.3) 10 (5, 13) 
   2016 10 9.8 (2.7) 9 (7, 14) 
   2017 13 9.5 (2.3) 10 (6, 12) 
   2018 1 7 (--) 7 (7, 7) 
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Table 6 
Pearson Correlation Coefficient, Between MNA-SF Score and Demographic/Clinical 
Variables 
 
  MNA-SF Total Score 
Demographic and Clinical Factors r p-value 
BMI  0.47 <.0001 
Age  -0.12 0.30 
Male (1=male;0=female) 0.063 0.60 
Physical Subscale Score 0.17 0.16 
Social Subscale Score -0.01 0.93 
Emotional Subscale Score 0.05 0.70 
Functional Subscale Sore 0.10 0.39 
FACT-G Index Total Score 0.12 0.30 
Surgery (1=surg; 0=no surg) -0.07 0.54 
Chemo (1=chemo; 0=no chemo) -0.0025 0.98 
Radiation (1=XRT; 0=no XRT) 0.092 0.44 
# Total Therapies* 0.024 0.84 
 
Note: All variables continuous unless otherwise noted as dichotomous 
* Total therapies counts the number of therapy modalities (previous surgery, 
previous chemotherapy, previous radiation, collected at baseline) that the 
patient listed, and ranges from 0 to 3. 
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Nutritional Risk and QOL Variables 
Hypothesis 2 was: Nutritional risk is associated with QOL including physical, 
emotional, social and functional well-being and overall QOL.  
            Data from the FACT QOL tool used in the regression analysis is presented in Table 7. 
The actual items and subscales are presented here in order to describe the specific factors 
associated with QOL. Hypothesis 2, Nutritional risk is associated with QOL including 
physical, emotional, social and functional well-being and overall QOL. It is in keeping with 
what the FACT-G QOL tool showed regarding the predictors of nutritional risk. The three 
predictors were BMI, previous chemotherapy, and the FACT-G physical subscale. These 
showed the importance of assessing BMI, previous chemotherapy and looking at other 
physical factors.  
 Variables were selected to be included in the regression analysis based on a review of 
the literature and recognition of the variables which are most commonly known to be 
associated with nutritional risk. Additionally, because this study was a secondary analysis of 
an existing database this study was limited to the data available.   
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Table 7 
 Quality of Life Metrics* 
 
Quality of Life Items, Subscales and Total mean(std) 
/median(min,max) 
Physical well-being subscale 23.1 (4.4), 24 (3, 28) 
Lack energy 2.4 (1.1) 
Have nausea 3.6 (0.7) 
Trouble meeting family needs 3.3 (0.9) 
Have pain 3.1 (0.9) 
Bothered by side effects 3.6 (0.8) 
Feel ill physically 3.7 (0.7) 
Forced in bed 3.4 (0.9) 
Social well-being subscale 25.5 (3.5), 26 (6. 28) 
Close to friends 3.7 (0.8) 
Emotional support from family 3.9 (0.7) 
Support from friends 3.8 (0.7) 
Family accepted illness 3.8 (0.7) 
Satisfied with communication about illness 3.9 (0.3) 
Feel close to partner 3.5 (1.3) 
Satisfied with sex life 2.8 (1.5) 
Emotional well-being subscale 17.4 (4.4), 18 (7, 24) 
Feel sad 3.4 (0.9) 
Coping with illness 3.7 (0.7) 
Losing hope with fighting illness 2.5 (0.9) 
Feel nervous 3.0 (1.0) 
Worry about dying 2.8 (1.3) 
Worry condition will get worse 2.0 (1.2) 
Functional well-being subscale 21.6 (4.3), 22 (6, 28) 
Able to work 3.0 (0.9) 
Work is fulfilling 3.1 (0.9) 
Able to enjoy life 2.9 (1.1) 
Accepted illness 3.8 (0.5) 
Sleeping well 3.0 (1.0) 
Enjoying things for fun 3.1 (1.1) 
Content with quality of life 2.6 (1.0) 
Overall FACT-G Index 87.5 (11.0), 89 (57, 108) 
 
 *QOL Scale: 0=Not at all to 5=Very much 
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Data from the MNA-SF is presented in Table 8. The instrument (MNA-SF) was 
selected to assess nutritional risk and was successfully implemented for all eligible subjects. 
Scores on the MNA-SF dictate that a score regarding a decline of food intake in the last three 
months was a score from 0, a severe decrease, 1 a moderate decrease, and 2 being no 
decrease in food intake. As far as weight loss in the last three months, the scores were 0 being 
a loss of  >7 pounds, the score of 1 meant patient did not know the amount of weight loss, 2 
was a loss between 2 and 7 pounds, and 3 was no weight loss or that of 2 or less pounds. 
Currently mobility was scored as 0 being unable to get out of bed without assistance, 1 was 
able to get out of bed or chair, but unable to leave the home, and 2 equaled able to leave the 
home. The next question asks if the patient has been severely stressed or ill in the last 3 
months with 0 being yes and 2 being no. Question “E” asks if the patient is currently 
experiencing dementia or severe sadness with 0 being yes, 1 being a mild yes, and 2 
measuring neither dementia of prolonged sadness. Those scores are then tallied and copied to 
page 2. The height and weight (BMI in essence) is then gathered and the patient is put into 
one of 3 groups, 0 being the worst and 3 being the best. That score is then added to the score 
from the first page and that is the total MNA-SF score. From 0-7 means a patient is 
malnourished, 8-11 is at-risk for malnutrition, and a score from 12-14 reveals a normal 
nutritional status. Results from the investigators database illustrated that 25 patients were 
normally nourished, 33 were at nutritional risk, and 15 were malnourished. The mean score 
of the MNA-SF was 9.7. This revealed that a substantial number of patient were either 
malnourished or at risk for malnutrition.  
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Table 8 
 MNA-SF Scores (possible values range 0 to 14) and BMI Data 
 
  MNA-SF Items                                 Screening Scale Score/values          n (%) 
1. Food intake  
Declined over last 3 
months 
0=severe 
1=moderate 
2=no decrease 
6 (8.2%) 
34 (46.6%) 
33 (45.2%) 
2. Weight loss in last 3 
months 
0=>7 lbs 
1=do not know amount of weight lost 
2= between 2 to 7 lbs 
3=no weight loss 
21 (28.8%) 
1 (1.4%) 
18 (24.7%) 
33 (45.2%) 
3. Current mobility 0=unable to get out of bed 
1=able to get out of bed with 
assistance 
2=able to leave home 
0 (0%) 
0 (0%) 
73 (100%) 
4. Stress or severe 
illness past 3 months 
0=yes 
2=no 
67 (91.8%) 
6 (8.2%) 
5. Dementia or  severe 
sadness 
0= severe dementia or sadness 
1=mild dementia and no severe 
sadness 
2=neither dementia nor sadness 
0 (0%) 
0 (0%) 
73 (100%) 
6. BMI group 0= BMI ≤19 
1= BMI 19 to <21  
2= BMI 21 to <23 
3= BMI ≥23 
5 (6.8%) 
11 (15.1%) 
13 (17.8%) 
44 (60.3%) 
7. Overall MNA-SF 
Score* 
0 – 7 
8 – 11  
12 – 14  
15 (20.6%) 
23 (45.2%) 
25 (34.2%) 
 
*Total all items. Groups: 12-14=normal nutrition, 8-11, at risk, 0-7= malnourished 
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Regression Analysis 
To address Hypothesis 2, stepwise multiple regression was used to find significant 
predictors of total MNA-SF score (Table 9).  
All 73 patients were included in the regression model, as there were no issues with 
missing data or any pertinent variables. In the univariate model, only BMI was found to be a 
significant predictor. We found that a four point increase in BMI was associated with a one 
point increase in MNA-SF score. The stepwise selection method was used to find a 
multivariate model from the list of predictors tested in the univariate analysis, using 0.15 
level for entry into the model and 0.10 significance level to remain in the model. The 
resulting model contained three final predictors: BMI, previous chemotherapy, and FACT-G 
physical subscale score.  
Physical subscale totals were positively associated with higher MNA-SF scores, with 
an 8-point increase in the subscale score corresponding to a one point increase in MNA-SF 
scores. Receiving chemotherapy tended to increase MNA-SF scores by 9%, but was only 
approaching significance, with p=0.09. Overall, the coefficient of determination for the 
model was rather low (R-square=0.26), which means our multivariate model only explains 
26% of the variability of the response variable (MNA-SF scores) using the predictors 
available. Thus, we believe that there may be predictors that are omitted that may help better 
explain the changes of MNA-SF scoring. 
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Table 9  
 Regression Analysis Results 
 
  Univariate Analysis Multivariate Analysis 
Predictor Parameter 
Estimate 
(stderr) 
p-value Parameter 
Estimate 
(stderr) 
 
p-value 
Age (continuous) -0.057 (0.054) 0.30 
 
    
BMI (continuous) 0.24 (0.054) <0.0001 0.28 (0.055) <0.0001 
 
Male (vs. female) 0.29 (0.55) 0.60 
 
    
Surgery (vs. no surgery) -0.43 (0.70) 0.54 
 
    
Chemo (vs. no chemo) 0.15 (0.70) 0.98 1.09 (0.63) 0.09 
 
Radiation (vs. no XRT) 0.43 (0.55) 0.44 
 
    
Number of Therapies (cont)* 0.071 (0.36) 0.84 
 
    
Physical Score 0.090(0.063) 0.16 0.12 (0.055) 0.03 
 
Social Score -0.0068 (0.078) 0.93 
 
    
Emotional Score 0.024 (0.063) 0.70 
 
    
Functional Score 0.055 (0.064) 0.39 
 
    
FACT-G Index Total Score 0.026 (0.025) 0.30     
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Chapter 5. Discussion 
Study Purpose 
The overall purpose of this study was to describe the nutritional risk of cancer patients 
65 years and older who are receiving systemic treatments via Phase I clinical trials. It 
describes the relationship between nutritional risk and the four domains of QOL (physical, 
social, emotional, and functional) (Figure 4).  
Summary of Findings and Implications  
 A sample of 73 patients, with a mean age of 71, were successfully accrued for this 
study from an NCI RO1 aimed at integrating supportive care for cancer patients on Phase I 
clinical trials using the MNA-SF instrument to assess for nutritional risk. Based on the 
previous literature this tool is a reliable and valid measure for nutritional risk in older cancer 
patients. The patient information needed to assess for nutritional risk is easily collected 
utilizing the MNA-SF as it gathers all the pertinent data in which to assess for nutritional risk 
in the older adult cancer patient. The MNA-SF is the most widely used tool in older adults, 
and is a highly sensitive and specific, validated and reliable nutrition screening and 
assessment instrument that can identify geriatric patients age 65 and above who are 
malnourished or at-risk of malnutrition. Validity was established confirming the six items of 
the MNA-SF scores with other measures of nutritional status (such as BMI and 
anthropometric parameters) with correlations of .83 to .86 (Kaiser, et al., 2009). It is 
recommended by national and international clinical and scientific organizations and has been 
validated in over 400 studies (Kondrup, et al., 2003; Salva, et al., 2004). The revised MNA-
SF makes the link to intervention easier and quicker (usually taking less than five minutes to 
complete), and is now the preferred form of the MNA-SF for clinical use (Rubenstein, et al., 
2001). It can be used in a wide variety of settings, requires no special training, no labs, and is 
available in 24 languages. It also identifies at-risk persons before weight loss occurs and 
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serum protein levels fall, and facilitates earlier intervention when response is most successful 
(Delacorte, et al., 2004). 
The population was predominantly Caucasian and overall well-educated. Most of the 
patients were Protestant and were married or partnered, living with a spouse or child. Most 
were retired with an annual income of $50,000 or greater. The participants were almost 
equally divided by male and female.  
As to the sample demographics (Table 3), it was interesting to note the mean age of 71: 
this may indicate the need for the nursing profession to pay even more attention to older 
adults as the population ages. As most of the sample was married or partnered, this would be 
an important factor to consider in future research or clinical practice, as other patients may be 
living alone and have less nutritional support (Bales, 2001).  
The study findings related to Hypothesis 1, nutritional risk is associated with 
demographic and disease/treatment variables of age, gender, and time since diagnosis and 
treatments, was of interest. Very few of the patients were newly diagnosed. Almost half were 
diagnosed in 2015 or earlier, thus most had a diagnosis of cancer for 4 or more years. This 
reflects that people are now living longer with their illness, having undergone multiple 
previous treatments and are now on a Phase I clinical trial. The effects of treatment may be 
cumulative and nurses should consider the entire treatment trajectory and treatment history to 
assess nutritional risk (Berry, et al., 2019). It is also interesting to note that these people with 
cancer had 2.2 other co-morbid conditions. This is very important to acknowledge as they 
may be experiencing symptoms from other comorbidities, which in turn are likely to affect 
their nutrition (Brugel, et al., 2014). It is disturbing to find that only 35% of this group had an 
advanced directive, and only 39% had identified a proxy decision maker. An important issue 
is that nutritional problems associated with advanced disease leads to decision making 
regarding instituting tube feedings or nutritional supplementation (Delacorte, et al., 2004). If 
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these people have no advanced directive or proxy designated, they may receive more 
aggressive treatments for nutrition than is clinically beneficial. 
 As to nutritional risk assessed through the MNA-SF and correlated with 
demographics, the only variable which showed a significant correlation was the BMI which 
is basically a computation of height and weight (Table 5). It is very important for nurses to 
closely monitor a patient’s weight because it is a huge predictor of a patient’s nutritional 
status (Berry, et al., 2019).  
Table 7 reveals some interesting information in the 4 domains of QOL, the physical, 
social, emotional, and functional. Physically the scale showed low energy being by far the 
biggest physical factor. This could easily be related to nutrition or weight loss and should be 
a symptom monitored closely (Freyer, et al., 2005). Socially, overall good scores were 
reported except in sexuality, which could also be a QOL issue and related to nutrition due to 
lack of energy, weight loss or body image. Emotionally, worry over their condition or worry 
about dying was a factor of most concern. This is also important to overall QOL and could 
well be related to nutritional status (Freyer, et al., 2005). Functional well-being revealed that 
the lowest item was their ability to enjoy life and satisfaction with overall QOL. These 
findings reveal how low QOL scores on the FACT-G could be related to nutritional risk.  
Nutrition is very closely associated with QOL and should be a priority in nursing care of the 
patient (Freyer, et al., 2005). 
 The MNA-SF scores presented in Table 8 show a moderate problem with food intake 
over the past 3 months, a little decrease in weight loss in the last 3 months, and stress or 
severe illness was very notable. It was interesting to see that the mean overall MNA-SF score 
was 9.7 (8-11 being at risk). This reinforces the need to closely monitor these patients. The 
MNA-SF allows the nurse to inquire of patients in a comprehensive manner as to food intake, 
weight loss, stress, and sadness, and yields much better information than merely taking a 
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person’s weight. It is the most validated tool for the elderly, yielding accurate and important 
information. It also requires minimal training of healthcare personnel and may be filled out in 
less than five minutes.  
Comparison with Other Studies 
 A study by Chen, et al. (2003) notes, as does this study that older cancer patients 
undergoing chemotherapy may experience toxicity but generally can tolerate it with 
some impact on independence, co-morbidity, and QOL levels. It is important to monitor 
these changes during geriatric oncology treatment. Chen’s study did have weaknesses 
such as small sample size and short follow-up. This study also was concerned with the 
older population due to recognizing the significance of this vulnerable population and 
their nutritional risk.   
 In a study done by Freyer, et al. (2005) which was also in the chemotherapy 
population utilized the CGA (of which the MNA is part) to predict tolerance to 
chemotherapy along with survival in older cancer patients. They found that the GCA 
could predict severe toxicity and overall survival of their patient population. A 
weakness found that geriatric assessment lacks standardization and there may have been 
patient bias. As with this study, there was a small sample size (n=60). This study was 
limited to a one-time assessment so survival was not assessed.  
Research by Ravasco, et al., (2005) noted that during treatment, nutritional 
interventions positively influenced outcomes and counseling was a similar/higher 
benefit.  
An additional study done by Hurria, et al. (2007) conducted a study identifying 
vulnerable older adults with cancer by administering the aCGA questionnaire and found 
that it was feasible for use in the outpatient oncology setting and helped identify the 
needs of geriatric oncology patients. The researcher also noted that prospective trials 
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are needed to determine the effectiveness of the interventions offered. Again, this study 
was only assessed at baseline, so effectiveness of interventions was not measured.  
The Stauder, et al. (2010) study hoped to assess geriatric assessment tools by 
determining the number of independent domains measured. A plethora of instruments 
were used in the research. A strength found was that the GA was feasible. Unlike this 
study, evaluation of screening instruments was not done, nor the cost of use in the 
United States (study done in Europe).  
 One study by Mudge, et al. (2011) utilized the BMI and MNA-SF instruments to 
understand the nutritional gaps in the older adult. The study is consistent with this 
investigator’s findings that inadequate nutritional intake is common, and patient factors 
contributing to poor intake should be considered in designing nutritional interventions.  
Another study by Hurria, et al. (2011a), like others desired to measure the toxicity 
of a vulnerable population by using the CGA in cancer clinical trials, and did so by 
assisting to modify and develop the CGA (again, the MNA is part of this tool). 
Additionally, Hurria, et al. (2011b) found that their study filled critical gaps in 
addressing frailty predictors for older patients, well within the parameters of this study. 
This study also found critical gaps in addressing risk in older patients.  
Research by Isenring,, et al.(2012) also used a multitude of tools attempting to 
establish validity of them. The MNA-SF was used and among the other instruments it 
was found that validity was established and can be used to triage nutritional care. A 
weakness pointed out was that there was a lack of a standard tool, making nutritional 
classification difficult.  
A study conducted by Soubeyran, et al. (2012). The researchers attempted to use 
validated tools in an effort to predict at-risk patients for early death in older patients on 
chemotherapy. They found that in patients older than 70, with cancer, a low MNA-SF 
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score predict early death. This would be in keeping what this study would expect to find 
in this population.  
In research done by Hoppe, et al. (2013) a host of tools were utilized (the MNA-
SF included). The study discovered that there is a correlation between low scores and 
early decline of older cancer patients. Some weakness revealed missing data, the lack of 
a physician to assess patients, and that there was no descriptive analysis of targeted 
patient activity. This study also revealed the lack of nutritional referrals, even though a 
low MNA-SF score was evident.  
Muffly, et al. (2013) conducted a pilot study evaluating the gaps in caring for the 
older adult cancer patient. The research found that the CGA, (again, the MNA is 
included), found that they uncovered a substantial prevalence of undocumented 
impairments in functional status, indicating what this study points out. There are huge 
gaps in the use of validated tools with a lack of a standardized program for evaluating 
these patients.  
In research done by Chapman, et al. ((2014), the CGA was also used to stress the 
importance of using this tool to assess and develop an individualize education and 
intervention plans. Several discordant trends were observed, along with challenges of 
territorial attitudes of physicians. However, the researchers felt they were able to 
establish a model of comprehensive geriatric oncology care in a cancer-based center. 
This researcher feels that a standard of care could easily be established in a 
comprehensive cancer center.  
Brugel, et al. (2014) expected to fine a direct clinical benefit using the CGA to the 
benefit of older cancer patients. The study did find this to be true, along with the need 
for a multidisciplinary approach to geriatric oncology care. This researcher also 
believes and nutritional program should be multidisciplinary.  
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A study by Wakabayashi & Sashika (2014) utilized the MNA-SF and BMI to 
assess the association between nutritional status and outcomes in older patients in 
rehabilitation. They found that most patients with low scores were malnourished and 
had poorer outcomes, just as this study would expect to find. However, it was pointed 
out that a weakness could be that interventions were inconsistently performed.  
Lastly, Kenis, et al. (2014) desired to compare the G8 and TRST tools (parts of the 
larger GA tool) to identify patients with a geriatric risk of functional decline and overall 
survival. Although these tools were found to be useful and simple to use, they could not 
define geriatric risk profiles. Again, this study measured nutritional risk at baseline 
only, therefore, overall survival was not measured.  
More recent articles cite that identifying malnutrition is common among patients 
with cancer, but there is very little attention given to its risks and consequences 
(Krishnasamy, et al., 2019). 
 The present study reinforces the literature review, newer articles and the need for 
nutritional risk assessment and prevention. The only difference noted by this 
investigator was that the MNA-SF was the only tool used in this study, and it is 
believed to render an adequate and accurate account of the older cancer patient 65 years 
and older who may be at nutritional risk and/or malnourished.   
Clinical Implications  
 A key clinical implication was that age is a significant factor, indicating that the older 
adult cancer patient beginning a Phase I clinical trial should be closely monitored regarding 
his/her nutritional assessment. Another recommendation would be to assure that patients and 
caregivers are educated by nurses on the information regarding nutrition and referred to 
nutritional services, as necessary (Berry, et al., 2019). Also, nurses in the clinical setting 
should be educated about the nutritional needs and assessment of older patients entering 
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Phase I clinical trials. The MNA-SF should be included as a standard of care for this 
population, as the nutritional aspect of care for older patients is very important (Kaiser, et al., 
2011). Weight should be monitored throughout the cancer trajectory. Other physical, social, 
emotional, and functional symptoms should also be assessed which could impact nutrition 
(for example fatigue, living alone, access to food, mobility, low income and depression). 
Many cancer patients are monitored and treated on an outpatient basis making it all that much 
more important for nurses to monitor them closely, identifying those at risk (Krishnasamy, et 
al., 2019). Research has also shown that systematic screening followed by nutrition referral 
for appropriate interventions is rare (Berry, et al., 2019). It has been found that only 50% of 
patients received professional dietary counseling (Hartmuller & Desmond, 2014). Regarding 
oncology nurses, 43% believed they were ill-equipped in having sufficient knowledge to 
provide advice on nutrition. This reflects the need to education nursing staff on this very 
important subject in order to provide the best nutritional care to oncology patients.  
 Research implications show that more research is needed in this area, with larger 
sample sizes. Clinical implications reveal the need to educate both healthcare professionals, 
along with patients and caregivers. Also, a better standard of care system should be in place. 
Limitations 
 This study included a small sample size (n=73), and patients were assessed at one 
time point, and not followed throughout the Phase I clinical trial trajectory. The participants 
were also accrued at a specialized national cancer center, on Phase I clinical trials, thus, were 
closely monitored.  Lastly, the regression analysis accounted for 26% of variance and there 
may be other issues affecting a patient’s nutritional status. 
Recommendations for Future Research 
 A recommendation for this study is to repeat the work within a larger sample. As this 
study was conducted with one assessment, at baseline, a more longitudinal study may be in 
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order to obtain better information.  Future studies should include patients from other settings 
such as community medical centers and healthcare systems. Samples might include a larger 
age (such as the oldest old) range and follow-up for nutritional risk over a longer period of 
time. Future research should look at other variables impacting nutrition.   
Conclusion 
 Nutrition is of the utmost importance to patients. It is part of the human element. 
Without it there is very little in life. Nurses are an integral part of nutritional assessment and 
risk, and this subject should be a very basic part of nursing education.  
 Nutrition impacts all dimensions of QOL and will be even more important in an aging 
population. Nursing research can contribute greatly to advancing this area of practice.  
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Appendix A                                             
Informed Consent for Nutritional Risk 
Informed Consent 
 
Title of the Study: Nutritional Risk in Cancer Patients 65 and Older Undergoing Phase I 
Clinical Trials. 
 
Principal Investigator: Anna Cathy Williams, MSN, PHN, Ed 
You are being asked to participate in a research project. This is a research project of 
Anna Cathy Williams, a PhD candidate, at the University of Hawaii, School of Nursing. 
This study is being conducted as part of Anna Cathy Williams’ dissertation towards 
completion of her PhD degree. This is a consent form to provide you with information 
about this study.  
 
 The purposes of this study are to examine the nutritional risk of cancer patients 65 and older 
undergoing Phase I clinical trials, and if age, education, gender, employment status, and 
income are related to or contribute to nutritional risk. You are being asked to participate in 
this study because you are a cancer patient and you meet the criteria for this study: you are 65 
or older; you can understand, speak, and write English. 
This study will consist of filling out 1 form: a demographic form about your background 
information and a questionnaire consisting of the physical, psychological, social, and 
functional domains of life. There is also a short nutritional form you will fill out. No personal 
identifying information such as name, date of birth, or social security number will be 
included with the study results. Anna Cathy Williams will have access to your medical 
records. Completion of the forms will last no longer than 30 minutes. Sixty-five older adults 
will be needed to complete this study.  
 
There will be little or no risk to participating in this study. Although name and date of birth 
will not be included in this project, small risk that you may experience include psychological 
pain when giving away information about your background information such as income, 
occupation, living arrangements, education, marital status, age, and gender.  
Although you may not benefit directly from this study, you may gain further understanding of 
nutritional risk. This study may also help the health care professionals in delivering health 
care to geriatric patients at nutritional risk.  
 
Please take your time to review this consent form and discuss any questions you may 
have with Anna Cathy Williams. If there are any words or sections in this consent form 
that you do not understand, please ask Anna Cathy Williams to explain them. Anna 
Cathy Williams will be available in the clinic during completion of the questionnaires. If 
you agree to take part in this research project, you will be asked to sign this consent 
form. It is important that you understand that taking part in this study is of your own 
free will (voluntary). You may decide not to participate, or you may decide to stop being 
in the study at any time, and it will not affect your health care services and/or your 
relationship with your physician now, or in the future.  
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If you have questions about this study, please contact Anna Cathy Williams directly.  If 
you have questions about your rights as a research subject, contact the University of 
Hawaii Committee on Human Studies at (808) 956-5007. 
 
Participant: 
I have read and understand the above information and agree to participate in this study. I have 
had the opportunity to discuss this study with Anna Cathy Williams, and I have had my 
questions answered. I take part in this study of my own free will, and I understand that I may 
withdraw from participation at any time.  A copy of this consent form has been given to me.  
____________________________________________________________________ 
Participant’s Name (print)                                       Signature          Date 
 
Principal Investigator: 
I, the undersigned, have fully explained the relevant details of this study to the participant 
named above and believe that the participant has understood and has knowingly given their 
consent. 
 
____________________________________________________________________ 
Principal Investigator’s Name (print)                      Signature          Date 
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Appendix B 
MNA-SF (Mini Nutritional Assessment Short Form) For Adults 65 years of Age and Older
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Appendix C  
Author Approval 
 
Hello Anna Cathy, 
 
Thank you for your interest in Nestlé’s Mini Nutritional Assessment Short Form (MNA-
SF®) and for inquiring about permission to use the MNA® in your study in older cancer 
patients at-risk for malnutrition. Nestlé is pleased to see the MNA-SF® being using in 
research and in clinical practice.   
 
Special permission is not required to use the tool in your study as long as absolutely no 
changes are made to the MNA-SF® form as downloaded from the MNA-SF® website 
(www.mna-elderly.com).  After completing your study, you will need to request permission 
to include the MNA-SF® in any manuscripts that you submit for publication.  You may 
submit that request to this same e-mail address.   
 
We look forward to seeing the results of your study.  Please let me know if you have further 
questions. 
 
Kind regards, 
 
Janet Skates 
Nestlé Health Science Consultant 
MNA-SF® Mini Nutritional Assessment Short Form Application 
1 (423) 239-7176 
janetskates@yahoo.com 
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Appendix D 
Demographic Disease Tool 
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Ferrell et al., 2019 
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Appendix E 
FACT-G Version 4 
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                             (Cella, et al., 1993) 
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Appendix F 
City of Hope IRB Approval 
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